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Abstract 
Introduction  
Understanding the different drug use trajectories for people who use or are considered at 
risk of using illicit drugs is important to reduce harms associated with severe drug use. 
This research aims to develop a better understanding of the different drug use pathways 
for young people by examining how identification with drug use predicts aspects of their 
future drug use. This longitudinal study tracked young people who use or are at risk of 
using illicit drugs to assess whether implicit and explicit identification with drug use predicts 
changes in their drug use over time. It also examined whether patterns of drug use such 
as frequency, recency, and multiple drug use impact the way a person identifies with 
drugs. 
Methods 
Two hundred and twenty-eight participants were initially recruited from homeless shelters, 
youth centres, drug health services, and parks where people who use drugs are known to 
frequent. Over a 20 month period, 78 of these original participants were recontacted and 
surveyed again. The survey included an Implicit Association Test that measured implicit 
identification with drug use and a questionnaire that collected information concerning illicit 
substance use, social networks, severity of dependence, reasons why people use drugs, 
and explicit identification with drug use. Ethics approval was obtained from the University 
of Queensland and University of New South Wales Human Research Ethics Committees. 
Recruitment was concentrated in the Sydney metropolitan area, a geographical area 
where a large proportion of people who use drugs are known to congregate.  
Results 
Participants who used drugs more regularly were more likely to be injecting as a main 
route of administration, to show greater severity of dependence, to be involved in drug-
using social networks, to have encountered significantly more negative consequences as a 
result of drug use, and to have started using drugs at a younger age. Significant positive 
correlations were found between explicit and implicit identification and seriousness of drug 
use, with identification with drug use being stronger among those participants that had 
used more frequently, more recently, and had used multiple drugs. These results suggest 
that patterns of drug use are tied up with the identity of the individual and that identification 
with drug use may be a marker of drug-using behaviour. However, longitudinal regression 
analyses revealed that neither implicit nor explicit identification with drug use predicted 
independent variance in the change in frequency, recency, or number of different types of 
drugs used over time. 
iii 
Discussion 
Implicit identification with drugs was not found to play a causal role in transitioning to more 
severe drug use over time. Although the findings do not support the research hypotheses, 
the results show that implicit identification reflects participants’ levels of current drug use 
and mirrors ongoing drug-using behaviour. Future longitudinal research should be 
designed to capture the more vulnerable and marginalised members of this at risk 
population, with a focus on measuring other variables that relate to entrenchment in a 
drug-using lifestyle as possible determinants of drug use pathways.  
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CHAPTER 1 - Trajectories of drug use   
Understanding the different drug use trajectories for people who use or are at risk of using 
illicit drugs is important in order to reduce harms associated with more severe drug use. 
Numerous studies have focused on variables that place young people at risk of using hard 
drugs and have found it to be a complex interaction of biological, psychological, social, and 
environmental factors (Downs & Rose, 1991; Fuller et al., 2002; van den Bree, Johnson, 
Neale & Pickens, 1998). However the different drug use trajectories for young people who 
are considered at risk are not well understood nor do we really know why some young 
people are more likely to transition from occasional drug use to regular use of harder 
drugs. Whilst research has identified several predictors that have been found to place a 
person at risk for long term drug use, these predictors do not explain why different 
individuals follow different drug use trajectories.   
One area that research on treatment and recovery from addiction has focused on is the 
importance of the identity of the person who uses hard drugs in understanding their 
recovery from drug use (Gibson, Acquah & Robinson, 2004; Hughes, 2007; Waldorf & 
Biernacki, 1981). This research on recovery from drug use proposes that the extent to 
which drug use is or becomes bound up with the identity of the individual may be a 
significant predictor of movement from occasional to regular drug use. The large body of 
existing research on the different variables that place young people at risk of using hard 
drugs has not focused on the identity of the person in terms of understanding different 
drug use patterns over time. Identity (or the way people see themselves) can be looked at 
both implicitly and explicitly and it is important to consider both aspects to see which of 
these, if any, are able to predict longer term use or movement to harder drug use.   
This research aims to develop an understanding of the different drug use trajectories for 
young people who use illicit drugs. I begin by discussing the harms associated with drug 
use, the prevalence of drug use in Australia, and the known predictors of drug use, which 
highlight the importance of studying drug use trajectories. The research then assesses the 
role identification plays in recovery from addiction and examines whether identification with 
drug use, both explicitly and implicitly, predicts aspects of drug use and explains 
movement from recreational use of drugs to use of harder drugs.   
Harms associated with drug use   
Harms associated with drug use place a large economic, social, and financial burden on 
society, making it essential to better understand and prevent movement into longer term 
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drug use. Globally illicit drug use takes a considerable toll on society with drug related 
mortality and morbidity increasing in both developed and developing countries. This places 
a strain on society, in terms of cost of treatment, loss of productivity, drug-related crime, 
and incarceration (Burns, 2014; Wodak, 1995). The burden of illness due to illicit drug use 
worldwide increased by 52% between 1990 and 2010 with dependence on illicit 
substances accounting for 3.6 million years of life lost through premature death and 16.4 
million years of life lived with disability in 2010 (Degenhardt et al., 2013). The health risks 
of illicit drug use increases with the frequency of use, quantity and type of drug use, 
duration of drug use, as well as the route of administration of the drug (Barrio et al., 2001; 
Degenhardt et al., 2013; McKetin et al., 2008). Injecting is associated with greater physical 
harms than using via other less invasive routes of administration. Currently there are some 
27 million people reported to be dependent on drugs with approximately 12.7 million 
people injecting drugs worldwide (Burns, 2014), however this figure is very likely to be an 
underestimate of the real prevalence of drug use.   
Drug harmfulness, the degree to which illicit substances cause harm, can be measured in 
a variety of ways, such as dependence, addictiveness, and physical risks. Marijuana, hash 
and mushrooms are generally considered to be soft drugs and are thought to carry less 
serious risks than hard drugs. Soft drugs are less inhibiting and addictive than hard drugs, 
often being defined as causing psychological, but not physical addiction (Kilpatrick et al., 
2000). More harmful drugs are referred to as hard drugs and are often linked to a 
particular route of administration, that being injecting (Gossop, Griffiths, Powis & Strang, 
1992; Nordegren, 2002). Heroin, cocaine, meth/amphetamines, prescription drugs being 
used non-medically, methadone, ketamine, benzodiazepines are all considered to be hard 
drugs.   
Australia has a strong culture of injecting drugs (Ciccarone, 2009; Warhaft, 2008). One of 
the reasons for this is that white heroin, traditionally found in Australia, is highly water 
soluble, acidic, and burns at much higher temperatures making injecting the ideal method 
for administration. In addition, almost all drugs are more effectively absorbed with a more 
intense rush when injected directly into the blood stream rather than administered through 
other means (Loimer, 1992; Nasir & Rosenthal, 2009; Swift, Maher & Sunjic, 1999). Hence 
in Australia, whilst the majority of heroin users initiate heroin use via injecting (Day, Ross, 
Dietze & Dolan, 2005) those who use other hard drugs long term often eventually move on 
to injecting as it results in a more cost effective method of using drugs (Tyler, 1995; Nasir 
& Rosenthal, 2009). The increased high obtained from injecting further fosters greater 
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dependence on the drug and encourages ongoing and possibly more frequent injecting 
(Gossop et al., 1995).   
The harms associated with hard drug use include psychosis, violent behaviour, overdoses, 
chronic diseases, infections, injecting-related injuries, and blood borne viruses, particularly 
HIV/AIDS and hepatitis C (HCV). In Australia, as in other developed countries, the biggest 
health concern for people who inject drugs is HCV which is a blood borne virus primarily 
transmitted via the sharing of equipment used to inject drugs. Ninety percent of new and 
80% of existing HCV infections are attributable to injecting drug use (Hajarizadeh, Grebely 
& Dore, 2013; Razalia et al., 2007; Robotin et al., 2004). Around 230,470 Australians are 
currently living with HCV and it is estimated that liver-related deaths due to HCV will claim 
more than 650 lives in Australia this year alone (The Kirby Institute, 2015).   
Young injecting drug users in particular are at a greater risk than other injectors because 
they are more likely than older more established users to reuse other people’s injecting 
equipment and more likely to overdose (Bailey et al., 2007; Bryant, 2014; Novelli, 
Sherman, Havens, Strathdee & Sapun, 2005). In addition young people who inject drugs 
are less likely to makes use of harm reduction and other healthcare services where they 
can access medical and social services, including receiving sterile equipment and being 
tested for HCV (Bailey, Huo, Garfein & Ouellet, 2003; Walker & Reibel, 2013; Wilson, 
Dean, Biro & Ciarrochi, 2003). Confidentiality breaches, embarrassment, and lack of 
knowledge of the services are often cited by young people as reasons for not accessing 
these services (Booth et al., 2004; Kang et al., 2006). As a result of their high risk drug-
using practices and the low attendance of health services by young injectors, the 
Australian Fourth National Hepatitis C Strategy has identified young people as a key 
priority group in order to prevent the spread of HCV infection among this vulnerable 
population (Australian Government Department of Health and Ageing, 2014; Roxburgh & 
Burns, 2015; Stafford & Burns, 2015). Even though research has shown that young people 
are more likely to engage in unsafe injecting practices (Buxton et al., 2004; Day et al., 
2005, Kerr et al., 2009), the prevalence of HCV is still lower in people under the age of 25 
compared to injectors overs the age of 36 (Iversen, Topp, Wand & Maher, 2012), 
presenting a unique opportunity to target intervention programs at young people (Bryant, 
2014). Given the high prevalence of HCV in the injecting population, a better 
understanding of ways to limit movement to harder drug use among this group of young 
users, who have not yet acquired HCV, is necessary to limit the spread of the virus.   
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Prevalence of drug use among young people in Australia 
Routine data collected in Australia suggests that drug use among young people is on the 
rise, especially with the increase in the use of crystal methamphetamine (street name ice) 
among young people (Degenhardt, Larney et al., 2016; Stafford & Breen, 2016). Findings 
from the most recent National Drug Household Survey show that people aged 20–29 are 
the most likely to use illicit substances (AIHW, 2014). More than one quarter (27%) of 
people in their twenties reported using illicit drugs in the previous 12 months, with 
cannabis being the most commonly used drug. Among people age 20-29, 20.8% reported 
having used cannabis in the last 12 months, followed by ecstasy (8.6%), cocaine (5.9%), 
and meth/amphetamines (5.7%). Cannabis use is also high across the adolescent age 
span; among young people aged between 12 and 17 years 15.4% have tried cannabis, 
19.2% tranquilisers, 10.6 inhalants and 3.4% amphetamines in the last year (Miller, Bridle, 
Goggin & Christou, 2012) 
The Illicit Drug Reporting System notes particular characteristics associated with young 
people who use harder drugs. The majority reported being polydrug users, multiple drug 
users, and daily cannabis users (Stafford & Burns, 2015). Polydrug use is the use of two or 
more illicit drugs at the same time or sequentially and multiple drug use is the use of two of 
more drugs over a sustained period of time (Bennett & Holloway, 2005). There are several 
reasons people choose to use more than one drug -- for example to increase the high, to 
reduce side effects, or due to unavailability of a particular drug -- but the synergistic and 
additive effects of combining drugs increases the risks of accidents, overdoses, and health 
and mental illness (Lee et al., 2012; Smit, Monshouwer & Verdurmen, 2002). Young 
people are more likely to experiment with polydrug use and multiple drug use and this 
further increases the risk of harms associated with drug use (McCabe, Cranford, Morales 
& Young, 2006; Rosenthal, Mallett, Rotheram-Borus, 2008). Based on recent findings from 
the Illicit Drug Reporting System (2014), heroin and methamphetamine have remained the 
two most commonly reported drugs last used, with around half of injecting respondents 
reporting daily or more frequent injecting. Of note is the significantly higher recent and 
frequent use of methamphetamine reported in the latest survey among people who inject 
drugs (Stafford & Burns, 2015). This survey reported crystal methamphetamine users to 
be younger, unemployed, and likely to use a variety of drugs. Crystal methamphetamine 
has a high purity and metabolises in the body quicker than other forms of 
methamphetamines and as such is more addictive than many other drugs (Degenhardt, 
Sara et al., 2016; Matsumoto et al., 2002,). Dependence on crystal methamphetamine has 
been linked to an increase in mental illness such as psychosis, may result in violent 
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behaviour and has also been associated with greater physical harms such as 
cardiovascular problems among young people as well an increased drug related fatalities 
(Degenhardt, Sara et al., 2016; Farrel, Masden, Ali & Ling, 2002; Hides et al., 2015; 
Mcketin, McLaren, Riddell & Robins, 2006; McKetin et al., 2008). The recent extensive 
coverage of the ice epidemic in the media has been aimed at young people and their 
families with warnings about the serious psychological, physical, social, and financial 
harms associated with use of crystal methamphetamine. When crystal methamphetamine 
is used recreationally it is usually smoked, but regular use of this drug quickly leads to 
dependence regardless of its route of administration (Degenhardt, Sara et al., 2016; Lee, 
Kay-Lambkin, McKetin & Baker 2008, McKetin, Kelly & McLaren, 2006; McKetin, McLaren 
& Kelly, 2005). About 10-15% of people who become dependent on crystal 
methamphetamine and manage to stop using, will relapse within a year (Lee, 2015; 
McKetin, Kelly et al., 2006, McKetin et al., 2012).   
The widespread increase in use of drugs, especially methamphetamines, by young people 
in the past five years is a concerning trend (Degenhardt, Larney et al., 2016). It is difficult 
to predict who will continue to use drugs recreationally and who will become dependent on 
them. This difficulty highlights the need for further research on drug use to identify factors 
that might limit movement to more serious drug use amongst this group of young people 
who are not yet entrenched in a serious drug-using lifestyle.   
Predictors of drug use among young people 
Previous research has focused on factors associated with substance use among young 
people and has identified several predictors that have been found to place an individual at 
risk of initiation to drug use (Brook, Brook, Richter & Whiteman 2006; Dube et al., 2003; 
Kaplan, Martin & Robbin, 1984; Kilpatrick et al., 2000). At risk in this context can be 
understood as young people with socio-demographic characteristics that may increase 
their likelihood of using drugs (Lea, Bryant, Ellard, Howard & Treloar, 2015). Illicit 
substances are more commonly used among young Australians than the Australian 
general population and usage tends to occur in greater concentration among those who 
are socially disadvantaged (AIHW, 2011; Bryant, Ellard, Fischer & Treloar, 2012). Sexual 
and physical abuse, delinquency, having parents with active alcohol dependence, low 
educational commitment, exposure to social networks of people who use drugs, and 
spending time in juvenile detention have all been found to be associated with movement 
into drug use, frequency of use, and heavy use of illicit drugs (Abelson et al., 2006; Dube 
et al., 2003; Fuller et al., 2002; Newcomb, Maddahian & Bentler, 1986; Obot, Wagner & 
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Anthony, 2001). Research suggests that experiencing a greater number of risk factors is 
associated with increased likelihood of substance abuse (Bry, McKeon & Pandina, 1982; 
Newcomb et al., 1986). These risk factors will be discussed in more detail below.  
  
Adverse Childhood Experiences 
Research suggests that childhood sexual and physical abuse is associated with movement 
into drug use (Heffernan et al., 2000, Kendler et al., 2000; Ompad et al., 2005). As the 
number of adverse childhood experiences increases, such as abuse, neglect, and 
household dysfunction, so too does the risk for developing substance abuse and 
dependence among young teenagers and adults (Dube et al., 2003).  
Dysfunctional family context 
Another strong predictor of substance abuse is dysfunctional family relationships and 
structure. Poor communication, excessive discipline, lack of parental warmth, weak parent-
child attachment, and family conflict have been found to predict initiation to drug use 
(Brook, Brook, Gordon, Whiteman & Cohen, 1990; Mason et al, 2007; Vellerman, 
Templeton & Copello, 2005). In addition, having parents that are dependent on alcohol 
and illicit drugs is associated with increased likelihood of usage of illicit substances 
(Abelson et al., 2006; Obot et al.,2001).   
Homelessness 
Even though a dysfunctional home environment is a known risk factor, homelessness is 
even more problematic. Research suggests that living on the streets and in shelters 
exposes youth to numerous stressors that are directly linked to risky behaviours and 
substance abuse (Baer, Ginzler & Peterson, 2003; Kipke, Montgomery, Simon & 
Iversonet, 1997; Milburn et al., 2009). In fact, recent homelessness over and above 
duration of early homelessness was found to be a significant predictor of drug use 
(Tompsett, Domoff & Toro, 2013).   
Peer networks 
Peer networks have been identified as particularly influential in drug use pathways. 
Exposure to social networks of people who use drugs (Creemers et al., 2010; Hawkins, 
Catalano & Miller, 1992; Simons-Morton & Chen, 2006) as well as deviant behaviour, 
delinquency, truancy, and low educational commitment (Bachman, 2008; Oetting & 
Donnermeyer, 1998; Townsend, Flisher & King, 2007) have also been found to play a 
significant role in movement into drug use, frequency of use, and regular use of illicit 
drugs. Socialising with peers that use drugs and being in an environment where drugs can 
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easily be obtained encourages positive attitudes towards drugs and increases the 
likelihood of drug use (Haller, Handley, Chassin & Bountress, 2010).   
Psychological Risk factors 
Low self-esteem, depression, psychological distress, and low sense of social responsibility 
are other factors that have been found to place a person at risk of the initiation to drug use 
(Boden, Fergusson, & Horwood, 2008; Kandel, 1982; Wild, Flisher, Bhana & Lombard, 
2004). The use of drugs may be seen as a self-medicating or a coping mechanism to deal 
with feelings of despair and anxiety.   
Age of first use 
If initial drug use occurs at a young age it is more likely to lead to continued use and 
dependence (Grant & Dawson, 1998; Johnson, 2001;Toumbourou & Catalano; 2005). The 
risk of developing drug problems is greater for those whose initiation into drug use begins 
during pre-adolescent and early adolescent years (Chen, Storr & Anthony, 2009). Hence 
how old a person is when they first use drugs may be an important predictor of future 
ongoing illicit drug use (Debeck et al., 2013; Fuller et al., 2002; Obot et al., 2001).    
Movement to harder drug use 
Most people who start using drugs occasionally never think they will end up injecting. 
Transitioning to injecting is a relatively new field of research which seeks to identify groups 
at risk of moving into injecting drug use with the focus on behavioural characteristics, 
social networks, adverse life events, and circumstances surrounding initiation (Fuller et al., 
2002; Lea et al, 2015; Roy, Nonn & Haley, 2008). As injecting drug use is a common route 
of administration of hard drugs in Australia, and given the harms associated specifically 
with injecting, it is important to understand factors that predict movement to harder drug 
use among young people. Research indicates that factors that increase the risk of 
transitioning from casual drug use to injecting drug use are a function of individual 
characteristics as well as the influence of social networks (Fergusson, Boden & Horwood, 
2008; Neaigus et al., 2006; Roy et al., 2008).   
Many of the risk factors described earlier that are associated with initiation to drug use are 
also found to be predictors of movement to injecting. Adverse childhood experiences, 
childhood emotional and physical abuse, exposure to physical violence, and 
homelessness have been identified as predictors of transitioning to injecting drug use 
(Fuller et al., 2002; McCrystal, Higgins & Percy, 2006; Bryant, Ellard, Morris, Fischer & 
Treloar, 2013). Additionally, research suggests that young people who have encountered 
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social disruptions or who have engaged in misbehaviour before age 16 such as getting 
into fights, truancy, and juvenile arrests as well as dropping out of school and showing low 
educational commitment are more likely to initiate to early transition to injecting (Crofts, 
Louie, Rosenthal & Jolley, 1996, Fuller et al., 2002, Obot & Anthony, 2000; Bryant et al., 
2013). Early sexual behaviour, particularly sexual encounters prior to age 14 is also 
associated with transitioning to injecting (Fuller et al., 2001; Roy et al., 1998, 2003). In 
addition, early sex-working among woman in particular was found to significantly predict 
transition into injecting (Fuller et al., 1999, 2002). Adolescents who start to use drugs at a 
young age are more likely to become polydrug users and progress more quickly to 
injecting (Fergusson & Horwood 1997; Grant & Dawson, 1998; Wu & Howard, 2007). 
Abelson et al. (2006) further identified that early transition to injecting was associated with 
having other family members who also inject.  
Additionally peer influences for young people are particularly powerful in understanding 
patterns of drug use, (Bryant et al., 2012; Fuller et al., 2003, 2005; Harocopos, Goldsamt, 
Kobrak, Jost & Clatts, 2009). Peer pressure in particular is noted as an important influence 
in transitioning to injecting, with a desire to experiment in a social context often reported as 
a reason for injecting (Bailey et al., 2007; Bryant & Treloar, 2007; Bryant et al., 2013). Day 
et al. (2005) provide evidence of the social nature of injecting as they found that more than 
one third of their sample of young heroin users had taught another person, usually a 
friend, to inject heroin with females often being initiated to injecting by their male sex 
partner (Bryant & Treloar, 2007; Crofts et al., 1996; Rhodes & Quirk, 1998; van Ameijden, 
Van Den Hoek, Hartgers & Coutinho, 1994). This research suggests that female initiation 
to injecting is strongly influenced by relationships with injecting partners, especially 
romantic-sexual partners.   
Drug pathways  
The section above outlines factors that may place a person at risk of initiation to drug use 
and ultimately transitioning to hard drug and injecting drug use. While these variables 
provide some evidence regarding who may transition to serious drug use, they do not 
explain why two people facing the same set of social or personal circumstances who are 
both exposed to a similar set of risk factors may follow different drug pathways in terms of 
their drug use.   
In an important major longitudinal study of drug use among adolescents in England, 
Parker et al. (1995) tracked over 700 young people for more than five years. They found 
that recreational drug use among young people had increased in popularity and become a 
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relatively normal part of young people’s social life. However this research focused on 
recreational drug use and not the use of hard drugs. Longitudinal research on young 
people who are at risk or using hard drugs is limited and more information is required to 
better understand these drug use trajectories.   
It is difficult to conduct longitudinal research assessing drug use trajectories of at risk 
youth for a number of reasons. Young people who are at risk are often a difficult group to 
study longitudinally because they tend to be transient in nature, making long term data 
collection very challenging. They may often be unreliable in maintaining contact and/or 
may be homeless, with contact details that tend to change. In addition, the illegality of 
most drugs as well as stigma and discrimination surrounding drug use and fears of breach 
of confidentiality means young people who are using drugs are often unwilling to speak 
openly about their drug practices. Thus, for a host of pragmatic reasons, it is easier to 
collect data from people who are already in treatment or who have ceased to use drugs 
than from those who are currently using drugs or who are at risk and whose pathways are 
still not known.  
Although we do not know exactly what transitions people into habitual drug use, we can 
perhaps extrapolate from the data showing what transitions people out drug use. Identity 
has been found to be important in recovery from drug use, suggesting that it may be 
important in the development of entrenched patterns of drug use. Several studies have 
focused on the issue of identity when examining recovery from dependent drug use, and 
discussed the necessity for disentangling individuals’ identity or sense of self from their 
drug use (Biernacki, 1986, McIntosh & McKeganey, 2000; Waldorf & Biernacki, 1981; 
Waldorf, 1983). These authors suggest that people’s identity becomes bound up with their 
drug use and to stop using drugs it is necessary to separate this identity. In a qualitative, 
exploratory study on the social psychological process of untreated recovery of dependent 
users, Waldorf (1983) found that once the decision to stop using had been made, new 
interests, social networks, and identities needed to be created to sustain this decision to 
stop using drugs. The sociological literature suggests that an important part of the 
recovery from the addiction process is the reconstruction of a nonuser identity. According 
to a study by McIntosh and McKeganey (2001), allowing the person to construct a new 
identity by focusing on reinterpreting their drug-using lifestyle in a destructive, negative, 
light is an essential part of the recovery process. Qualitative research that has addressed 
these ideas, has found the reconstruction of a new non-addict identity central to the 
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recovery process, emphasizing the link between recovery from drug use and changes in 
identity.  
This prior, largely qualitative research raises the possible importance of identity in 
understanding transitions to more entrenched drug use (Gibson et al., 2004; Hughes, 
2007; McIntosh & McKeganey, 2000). Gibson et al. (2004) refer to entangled identities 
whereby people take on a drug-using identity made up of routines and habits directly 
related to their drug use, which replaces their non-user identity, in some cases leaving 
them unable to even remember having a non-user identity. Such data suggest that the way 
a person identifies with their drug use may be important in understanding various aspects 
of their drug use, such as increased frequency of use or greater entrenchment in a drug-
using lifestyle. Findings from the literature cited above suggests that the extent to which 
drug use is bound up with the identity of the individual may be a significant predictor of 
their movement from occasional drug use to regular use of harder drugs. Almost all of the 
research cited above is qualitative and there is little quantitative research that has 
examined the importance of identity in understanding drug use or recovery from drug use. 
Based on the literature it may be that those who identify more strongly with their drug use 
are more likely transition into harder drug use. The goal of this thesis is to examine the role 
that identification with drug use has on changes in drug use over time using quantitative 
methods. By tracking young people over time, this research aims to examine how 
identification with drug use relates to drug use pathways focusing on frequency, recency, 
and severity of use.  
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CHAPTER 2 - Implicit identification with drug use 
Traditional models in social psychology assumed that attitudes operated on a conscious 
level (Allport, 1935; Katz & Braly, 1935; Thurstone, 1931). Over the past 30 years, there 
has been considerable evidence to the contrary that social behaviour and human cognition 
often operates outside of conscious control and that people’s attitudes need not be at a 
level of conscious awareness to have an effect on behaviour (Bargh & Chartrand, 1999; 
Fazio, Jackson, Dunton & Williams 1995; Jones, Pelham, Mirenberg & Hetts, 2002). 
Implicit attitudes are the unconscious traces of previous experiences that can influence 
social behaviour, feelings, and perceptions (Greenwald & Banaji, 1995). Measures of 
implicit attitudes tap into cognitions that may not be accessible at a conscious level and 
may be different from the publicly expressed opinions and beliefs. With the advent of 
techniques to measure implicit attitudes, such as Semantic Priming Measures 
(Wittenbrink, Judd & Park, 1997), the Go/No Go Association Task (Nosek & Banaji, 2001), 
Sequential Priming Tasks (Fazio, Sanbonmatsu, Powell & Kardes, 1986; Gawronski, 
Hoffman & Wilbur, 2006) and the Implicit Association Test (IAT) (Greenwald, McGhee & 
Schwartz, 1998), social psychology witnessed a resurgence of research in this field of 
implicit social cognition. These measures have been used extensively to examine 
concepts such as attitudes, stereotypes, self-identity, and self-esteem that may differ at an 
explicit level (Cunningham, Nezlek & Banaji, 2004; Nosek et al., 2007; Nosek & Riskind, 
2012).   
By using implicit association measures to assess the associations that may exist outside of 
conscious awareness and control, researchers can overcome problems such as when 
participants are motivated to control their responses or simply may not know the answers 
(Fazio & Olson, 2003; Strack & Deutsch, 2004; Wilson, Lindsey & Schooler, 2000). For 
example, responses may be contaminated by social desirability bias whereby participants 
respond in a way that is overly positive about themselves or in a way that is intended to 
represent themselves more positively from a social perspective (Greenwald, Poehlman,  
Uhlmann & Banaji 2009; Paulhus & Reid, 1991). Self-report measures allow individuals to 
mask their true feelings and prejudicial attitudes on sensitive topics such as racism and 
stereotyping (Dovidio, Gaertner & Validzic, 1998; Egloff & Schmukle, 2002; Fazio & Olsen, 
2003). For example, individuals can fake answers on explicit measures to hide their 
prejudicial feeling towards homosexuality, but were not able fake responses on an implicit 
measure (Banse, Seise & Zerbes, 2001). In other situations participants may be unaware 
of or simply unable to answer what is actually being asked of them in an explicit attitude 
task. In some instances, people are not able to accurately introspect (Nisbett & Wilson, 
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1977). This may result in people making inaccurate assumptions about their own attitudes 
(Bargh, Chaiken, Govender & Pratto, 1992; Greenwald & Banaji, 1995; Jones et al., 2002). 
This inaccurate introspection or limited awareness is not intended to deceive, and often 
the person is confident about the accuracy of a response even though it may be incorrect. 
According to Nisbett and Wilson (1977) people are motivated to construct a plausible 
explanation for their thoughts or behaviour, but in reality they are often inaccurate, 
misinterpreted, or guesses. In order to overcome this problem of accurately knowing why 
people feel and behave the way they do, it is necessary to tap into these unconscious 
processes.   
Implicit Association Test 
The Implicit Association Test (IAT) was developed by Greenwald et al. (1998) and has 
become the most well-known and commonly used measure of implicit attitudes. The IAT 
has been shown to have good reliability, internal consistency and construct validity 
(Bosson, Swann & Pennebaker, 2000; Greenwald & Nosek, 2001; Lane, Banaji, Nosek & 
Greenwald, 2007), as well as being resistant to known problems faced by self-report 
measures (Banse et al., 2001; Egloff & Schmukle, 2002). The IAT has been used to 
examine a variety of concepts such as stereotypes (Nosek, Banaji & Greenwald, 2002; 
Nosek et al., 2009), prejudice (Dovidio et al., 1998; Kawakami, Dion & Dovidio, 1998), 
anxiety (de Jong, Pasman, Kindt & Van den Hout, 2001; Egloff & Schmukle, 2002), eating 
disorders (Roefs & Jansen, 2002), and self-esteem (Greenwald & Farnham, 2000). The 
IAT has also been shown to predict current and important social behaviours better than 
explicit measures (Nock & Banji 2007a, 2007b; Nock et al., 2010).   
The IAT measures implicit associations by assessing the strength of an association 
between target concepts and negative or positive attributes (Greenwald et al., 1998). The 
strength of association is measured in terms of the response times in a computer-
administered categorisation task. A typical IAT involves a series of tasks, wherein an 
individual is asked to categorise concepts as rapidly as possible. This test is based on the 
assumptions that reaction times are quicker when positively associated concepts share the 
same response key than when concepts that share a response are negatively associated 
or not associated. For example faster responses for White + positive / Black + negative as 
opposed to White + negative / Black + positive would indicate positive feelings towards 
Whites and/or negative feelings toward Blacks (Greenwald et al., 2009).   
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Implicit associations and drug use 
The majority of work on transition into regular drug use relies on explicit, self-report 
measures. It may be that these explicit measures are not able to tap the attitudes and 
feelings people have about their drug use, especially given the social stigma surrounding 
heavy drug use. The stereotyping of people who inject drugs as “junkies” and non-
productive, socially deviant members of society has led to the stigmatisation of and 
discriminatory behaviour towards people who use heavy drugs (Elliott & Chapman, 2000; 
Goffman, 1963; Paterson, Backmund, Hirsch & Yim, 2007). These negative attitudes 
towards people who inject may become internalised and affect the way people see 
themselves (Crocker, Major, Steele, Gilbert & Fiske, 1998; Gilmore & Somerville, 1994). 
Literature shows that this stigma (internalised and enacted) has a significant negative 
influence on the emotional, mental, and physical well-being of the individual (Link, 
Struening, Rahav, Phelan & Nuttbrock, 1997; Sayles, Wong, Kinsler, Martins & 
Cunningham, 2009; Young, Stuber, Ahern & Galea, 2005). The ongoing stigma faced by 
people who use hard drugs may impact their willingness to openly discuss and be honest 
about their drug-using behaviours, and they may simply be unaware of or unable to 
accurate reflect on their identification with drugs. In order to overcome this potential 
problem, it may be necessary to measure implicit identification with drug use.  
Over the past decade the use of implicit measures in research on addiction has increased, 
providing a greater understanding of patterns of drug use and recovery. Several studies 
have looked at the role that implicit cognitive processes play in alcohol consumption. Both 
implicit attitudes towards and identification with alcohol seem to play a role in alcohol 
consumption, with people who have positive implicit attitudes towards alcohol more likely 
to consume more alcohol (Wiers, van Woerden, Smulders & de Jong, 2002, Wiers, van de 
Luitgaarden, van den Wildenberg & Smulders, 2005, Thush & Wiers, 2007 ). Heavy and 
light drinkers also differ in their implicit arousal toward alcohol, with heavy drinkers holding 
stronger implicit association between alcohol and arousal and weaker implicit sedation 
associations. Research further shows that implicit identification with alcohol is associated 
with future risky drinking behaviour (Casey & Dollinger, 2007; Conner, Warren, Close & 
Sparks, 1999; Lindgren et al., 2013; Wiers et al., 2002). For example, college students 
who show a greater implicit identification with alcohol are more likely to consume 
increased amounts of alcohol and have more alcohol-related problems (Lindgren et al., 
2013). Perhaps implicit identification with drug use could also have a powerful predictive 
influence on drug use pathways and movement to harder drug use over time. 
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Extending this work from alcohol to drug use, researchers have assessed the role implicit 
identification has on patterns of drug use, particularly in relation to treatment outcomes 
(Brener, von Hippel, & von Hippel, 2012; Rooke, Hine & Thorsteinsson, 2008; Wiers & 
Stacey, 2006). Among participants in a treatment facility, Brener et al. (2012) found a 
correlation between implicit identification with heroin and severity of dependence. 
Individuals who were in the treatment facility for heroin use, showed a stronger implicit 
association between self and heroin than those who were at the residential rehabilitation 
centre for alcohol use. This study suggests a possible link between drug of choice and 
implicit self-identification that may provide new understanding of pathways of use. Greater 
implicit identification with drug use seems to predict dependency and severity of drug use. 
At the same time, greater implicit associations between the self and drug use might 
emerge from more frequent drug use and entrenchment in a drug using network. The 
possible cyclical relationship that exists between seriousness of drug use and implicit 
identification with drugs may be self-perpetuating with those who implicitly identify with 
their drug use becoming more frequent users and those who use more frequently 
identifying more with their drug of choice. These studies point to the importance of implicit 
cognitions, especially in a sensitive and highly stigmatised context of drug use. Given 
these findings it is conceivable that implicit identification with drug use may be a key factor 
in understanding individual patterns of drug use over time.   
By extrapolating from data showing what transitions people out of drug use, we might gain 
a better insight into what transitions people into drug use. Implicit identification with drug 
use has also been shown to play a role in determining the amount of time people are 
willing to spend in residential rehabilitation programs. Wolff, von Hippel, Brener and von 
Hippel (2015) found that implicit measures of identification with drug use were able to 
predict duration in rehabilitation when explicit measures of identification were not 
predictive. This finding adds to the body of evidence suggesting that implicit identification 
with drug use may be important in understanding transitions to drug use, but the role of 
identification as a predictor of drug use pathways has not yet been examined quantitatively 
at either an explicit or an implicit level. 
Despite the absence of predictive work in the domain of drug use, there is evidence that 
implicit attitudes can predict future behaviour. A landmark study by Nock et al. (2010) 
found that implicit attitudes accounted for unique variance in future suicide attempts 
beyond other measures such as self-reported suicide ideation, prior number of suicide 
attempts, and mood disorders. If implicit identification with death is able to predict suicidal 
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behaviour, then the possibility exists that implicit identification with drug use might be able 
to predict ongoing pathways of drug use and abuse. Implicit identification with drug use 
might be useful in predicting the choices people make that lead to drug dependency.  
Conclusion 
Previous research has identified several predictors that place an individual at risk of 
initiation to drug use and of transitioning to harder drug use for young people (Bryant et al., 
2012; Fuller et al., 2002, Heffernan , 2000;Lea et al., 2015; Rice et al., 2005). However, 
what remains largely unexplained is why some individuals who are considered at risk of 
illicit drug use go on to more frequent and regular use while others do not. Previous 
research in treatment and recovery from drug use emphasises the link between drug use 
and identity and suggests that the identity of an injecting drug user might be an important 
link to various aspects of their drug use (Biernacki, 1986; Gibson et al., 2004; Hughes, 
2007, McIntosh & McKeganey, 2000). This research has until now focused on the explicit 
identity of the user when trying to understand the different pathways of use and recovery. 
For some people, the use of alcohol and drugs becomes an important part of the way they 
see themselves. Their views of themselves are tied up with their drug-using behaviour, 
routines, and lifestyle. This identification with drug use may differ at a conscious and 
unconscious level of awareness. Thus, it is possible that implicit identification with drugs 
may be a useful tool in predicting various aspects of future drug use. This study aims to 
explore the possibility that identification with drug use is a significant and independent 
predictor of movement from recreational to habitual use of drugs over time.  
  
Outline of the research 
Based on the theory outlined above and in Chapter One, the following was hypothesized:   
1) Implicit associations between self and drug use would be stronger among people who 
use harder drugs regularly than among people who use softer drugs recreationally.   
2) Participants who showed an implicit association between self and drug use would show 
an increase in the frequency and recency of their drug use.   
3) Increased frequency/recency of drug use would be associated with stronger implicit 
associations between self and drug use over time.   
4) Participants who showed a strong implicit association between self and drug use, 
would show an increase in use of multiple drugs over time. 
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CHAPTER 3 - Methodology 
This research examined whether an individual’s identification with drug use can predict 
aspects of their future drug use, such as their movement from use of recreational drugs to 
use of harder drugs and/or injecting as a main route of administration. It is also examined 
whether patterns of drug use such as the frequency, recency and multiple drug use, may 
impact the way a person implicitly identifies with drugs. The goal of the study was to track 
young people longitudinally who were either currently involved in illicit drug use or at risk of 
initiating illicit drug use, to assess the association between their implicit and explicit 
identification with drug use and change in their drug use over time (see Figure 1). 
 
Figure 1: Analysis to assess association of identification with drug use over time 
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Sample 
Potential participants who met the following criteria were invited to participate in the study: 
(1) aged 16 to 28 years, (2) using illicit substances or considered to be at risk of using, 
which was defined by the known predictors of being homeless, living on the streets or in 
shelters for at least three nights in a row over the past 12 months and/or having close 
friends or family members that use drugs (Lea et al., 2015). Two hundred and twenty-eight 
participants took part in the first phase of the research. Nine participants (3.9%) had never 
used illicit substances but still met the criteria for being considered at risk as they were 
either living in shelters or were homeless. Of the 228 initial participants, 78 were 
successfully recruited for the follow up session during the course of a twenty month period. 
The average time lag between completion of the measures at Time 1 and Time 2 was 5.5 
17 
months, and ranged from 61 to 594 days between the initial and follow up testing session 
(M = 164 days, SD = 113.5 days). All measures were collected on a laptop computer with 
the researcher present. Participants were reimbursed $25 for survey completion at each 
time point.   
The mean age of participants, approximately 22 years, was similar at Time 1 and Time 2 
with the average age of first use of drugs being 14 years. More than half the participants in 
both surveys were male. Just over half the respondents had completed no more than year 
10 of schooling and just over half relied on benefits as their main form of income. 
Approximately half the participants reported injecting as their main form of administration 
of illicit substances. See Table 1 for additional demographics and participant 
characteristics. 
Table 1: Participant characteristics 
 Time 1  
n = 228 
Time 2  
n = 78 
Age, M (SD) 22.36 (3.68) 22.59 (3.64) 
Age of first use, M (SD) 14.3 (3.15) 14.52 (2.61) 
Gender % % 
    Male 65.8 65.4 
    Female 29.8 29.5 
    Transgender 3.9 3.8 
    Intersex 0.4 1.3 
Highest level of education % % 
    Primary 9.2 14.1 
    Up to year 10 57 56.4 
    Up to year 12 18.4 14.1 
    Diploma/trade/university 15.4 15.4 
Main source of income % % 
   Benefits 54.8 52.6 
   Full time work 5.3 5.1 
   Part time/casual/contract 19.3 16.7 
   Student allowances 8.3 6.4 
   Dependent on parents 3.1 3.8 
   Illegal/crime 2.2 3.8 
   No money/no income 3.1 7.7 
   Other 3.9 3.8 
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Recruitment 
Prior to commencing the research, ethics approval was obtained from the University of 
Queensland and University of New South Wales Human Research Ethics Committees. 
Recruitment sites for the study were concentrated around the Sydney metropolitan area, a 
geographical area where a large proportion of people who use drugs are known to 
congregate. Young people at risk of drug use are known to be hard to reach through 
traditional health and harm reduction services and they tend to be less willing than older 
people to talk about their risk practices for fear of getting in trouble with the law (Bryant et 
al., 2012; Sears, Guydish, Weltzien & Lum, 2001). Additionally, young people are unlikely 
to attend health services of any form (Booth et al., 2004; Youth Affair Council of WA, 
2006). Hence there are limited facilities that provide a point of access to young people who 
use drugs. As a result, the strategy for data collection involved extensive networking 
through non-traditional means such as homeless shelters, youth centres, drug health 
services, parks, and word of mouth. Because of the known difficulties involved in recruiting 
this type of sample, much of the initial recruitment centred on building up trust with young 
potential participants and networking with them. Word of mouth and snowballing proved to 
be the best way of recruitment, but was a slow and painstaking process. In addition, young 
at risk participants are very transient, living in temporary accommodation, shelters, on the 
streets, or in custodial settings. They are often unemployed, or not at school, and their 
contact details change over time. Hence tracking participants for the follow up survey 
proved extremely difficult and time-consuming.   
Service directors of five relevant youth organisations and one Needle and Syringe 
Program (NSP) were contacted, informed of the study and agreed to be involved to assist 
in recruitment. Some of these youth organisations offer shelter and food to young people 
on a temporary basis whilst others provide a safe place for young marginalised people to 
have access to recreational, health, harm minimisation, and welfare services. Staff at the 
various services were encouraged to inform their clients about the study, and to ask those 
interested in participating a series of questions to ensure they met the criteria. I attended 
the different services throughout the process to assist with recruitment of eligible 
Main route of administration of illicit drugs % % 
  Smoking 42.5 50 
  Injecting 52.7 47.4 
  Snorting 1 1.3 
  Swallowing 3.9 1.3 
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participants and to recontact them. In addition to recruitment through these services, 
participants were recruited through non-traditional means. For example, I spent several 
months loitering in parks, train stations, and communal areas where eligible participants 
could be found. By establishing trust with potential participants and with assistance from 
those participants who had taken part in the first phase of the research, over a twenty 
month period the sample groups for both phases were collected.  
Procedure 
Once a person agreed to participate, I outlined the aims of the research and obtained 
written informed consent from them. I administered the survey to participants on a laptop 
computer in a quiet space, and was available to answer questions. The survey took 
approximately 30 minutes to complete. Participants who completed the survey were asked 
whether they would be willing to complete a follow up survey in approximately 3 months’ 
time. If they consented, they were asked to provide their name, contact telephone number 
or email address. To maximise the likelihood that these participants could be recontacted 
for the time 2 data collection, they were also asked to provide the contact details of a close 
friend or relative as another means to find them for the follow up survey.   
Measures 
Implicit association Test 
An Implicit Association Test (IAT) (Greenwald et al, 1998) was used to measure implicit 
identification with drug use. An IAT involves a series of discrimination tasks, wherein two 
concepts or a concept and attribute are introduced in the first two steps (e.g., Black/White 
in one task and positive/negative valence in the next task). Categories for each of these 
stimuli are assigned to a left or right key on the keyboard (e.g., by pressing the E and I 
keys). In the middle of the screen a word or picture that is typically associated with the 
categories appears (e.g., faces of Black/White people or words such as “sunshine” or 
“vomit”) and the person is asked to assign the word into the appropriate category by 
pressing the appropriate left-hand or right-hand key. The compound task involves sorting 
both concept and attribute to the left and right where each side has two categories 
assigned to it (e.g. Black/negative and White/positive). In the next compound task, there is 
opposite pairing of the concepts and attribute (e.g., White/negative and Black/positive). 
The IAT then compares the relative times for sorting these concepts. The basic 
assumption is that the more closely associated the two concepts are that are assigned to 
the same response key, the more rapidly one should be able to respond. By measuring 
strength of automatic associations, the IAT is able to measure private attitudes that we 
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may not be willing to share, as well as attitudes that we may not be aware that we hold. 
Research on the psychometric properties of the IAT have shown good internal 
consistency, test-retest reliability, predictive validity, convergent and discriminant validity 
(Egloff & Shmukle, 2002; Greenwald & Farnham, 2000; Greenwald & Nosek; 2001; 
Greenwald, et al, 2009; Lane, et al, 2007 ).   
The IAT used in this research was adapted from one used in prior research by Wolff et al. 
(2015). Their IAT was pre-tested with eight staff members at the New South Wales Users 
and Aids Association (NUAA). NUAA is as an independent, user-driven, community-based 
organisation that advocates for people who use drugs (particularly those who inject drugs), 
and was established by a group of drug users, their friends, and families. The staff 
members, all either current or past drug users, completed the task with the researcher in 
the offices at NUAA. They commented on the choice of words in the instrument and notes 
were taken. The pre-test revealed that smashed and wasted were suitable words strongly 
associated with drug use and clean and sober were suitable words associated with not 
using drugs. 
The IAT consisted of seven steps: in the first step participants completed 20 practice trials 
in which they classified words relevant to identity (I, myself, my, vs they, them, their) as 
quickly as possible, with the “E” key being pressed when a word belonging to Not Me 
appears and the “I” key when a word belonging to Me appears. Next they completed 20 
practice trials to classify the words associated with drug use (smashed, wasted, vs clean, 
sober) which were labelled as Not Using on the “E” key and Using on the “I” key. The 
words relating to identity and drug use were then randomly ordered and participants 
completed the two classifications simultaneously with the “E” key being pressed for words 
that were related to Not Using and Not Me and the “I” key for words associated with Using 
and Me. After 20 practice trials with this compound task, participants then completed a 
block of 70 such trials. The key assignments were then switched so that participants then 
completed another 20 practice trials with drug-use words, but this time the “E” key was 
pressed for Using and the “I” was pressed for Not Using. The critical phase then occurred 
when participants were asked to respond to Using and Not Me words on one key and Not 
Using with “Me” on the other key. Participants completed 20 practice trials with the 
switched combination of Using being paired with Not Me on the “E” key and Not Using and 
Me on the “I” key. Finally the participants complete a block of 70 such trials (see Figure 2).  
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Figure 2: Example of the IAT 
 
The left screen is an example of the pairing task in stages 3 and 4 while the right screen is 
an example of the pairing in stages 6 and 7. 
 
 
Scoring the IAT 
When scoring the IAT, response times associated with incorrect answers (17% of all 
scores at Time 1, 14% at Time 2)1 were removed (as in von Hippel, Brener, & von Hippel, 
2008; Wolff et al., 2015). Response times were then winsorised so that scores less than 
300msec (1.5% of all scores at Time 1, .7% at Time 2) were set to equal 300msec and 
scores that were greater than 4 seconds (1% of all scores at Time 1, 3.9% at Time 2) were 
set equal to 4 seconds. This scoring allows for control on excessive slowness or excessive 
speed from participants by recoding latencies outside the upper and lower boundaries to 
the boundary values of 300msec and 4 seconds. To create an IAT score from these 
adjusted response latencies for each participant, the procedures of Greenwald, Nosek and 
Banaji (2003) were followed, such that the mean response time when me was paired with 
using was subtracted from the mean response time when me was paired with not using, 
and this difference score was then divided by the overall standard deviation. The result of 
                                                          
1 One participant was eliminated who had an average accuracy of less than 60%. 
Not Using     Using 
Not Me         Me 
   
       Smashed 
 
Using               Not Using 
Not Me             Me 
 
  Clean 
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this scoring procedure is that higher numbers indicated a stronger implicit association 
between self and drug use (indicating that people respond more rapidly when me is paired 
with using than with not using).  
 
Questionnaire 
The questionnaire was pretested with the same eight NUAA volunteers who pretested the 
IAT and was altered slightly to incorporate their comments and suggestions, which 
focussed on removing any ambiguities and better reflecting the vocabulary of a drug user. 
Participants completed the questionnaire on the laptop computer. The questionnaire was 
designed to collect information regarding illicit substance use, age of first drug use, 
frequency of drug use, recency of drug use, multiple drug use in the last 12 months, as 
well as questions about drug use among their friends, and difficulties associated with drug 
use (such as trouble with police or at school). Three scales were included that were 
designed to measure severity of dependence, understanding reasons that people use 
drugs, and explicit identification with drug use. The scales are outlined in more detail 
below. Demographic data were also collected.   
Severity of dependence (SDS) 
The Severity of Dependence Scale (Gossop et al., 1995) is a five item scale used to 
measure the degree of dependence, anxiety, and impaired control over use of illicit 
substances in the last month (e.g. Over the last month, did you wish you could stop using 
permanently?; see Appendix 1). Responses were provided on a 4 point scale (0-3) from 
never or almost never to always or almost always with higher scores indicating greater 
dependence on illicit substances. Internal reliability in this study was found to be good 
(Time 1 administration; α =.78, Time 2 administration; α = .82). 
 
Functions for Substance Use Scale 
There are a number of different motivations that people cite for using drugs, from 
celebrating with friends to avoiding unpleasant emotional states (Christo, 1998; McKay, 
Murphy, McGuire, Rivinus & Maisto, 1992; Parks & Kennedy, 2004). This survey included 
seven questions that had been adapted from a 17-item Functions for Substance Use Scale 
(Boys, Marsden & Strand, 2001) that examined the reasons young people give for using 
drugs. Participants were asked if they had ever used a drug to fulfil each specific function. 
The original scale covered five domains of reasons for substance use, namely changing 
mood, physical effects, social purposes, to facilitate activities, and to manage effects from 
other substances. The scale used in this study focused on two of the domains: 1) changing 
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mood and 2) social purposes as a significant association between these two domains and 
frequency of drug use has been found by Boys et al. (2001). Respondents were asked 
whether they had used illicit drugs to fulfil a specific purpose such as changing mood – for 
example, Using drugs makes me feel better when down or depressed -- or for a social 
purpose – for example, Using drugs makes me feel more confident or more able to talk in 
a social situation (see Appendix 1). These questions were responded to on a 7-point scale 
from strongly disagree (1) to strongly agree (7), with higher scores being indicative of 
drugs being used to enhance social interaction and mood. The scale showed good 
reliability at Time 1 (α=.85) and Time 2 (α=.84).    
Explicit identification scale 
A nine item scale designed to measure explicit identification with drug use was included in 
the survey. This scale was adapted from the Smoker’s Self-concept Scale and the 
Abstainer Self-concept Scale both developed by Shadel and Mermelstein (1996). 
Participants were asked the extent to which they agreed or disagreed with items designed 
to measure explicit identification with drug use - for example, Using drugs is part of the 
way I see myself, and, It’s easy to imagine myself as someone who doesn’t use drugs at 
all (see Appendix 1.) These questions were responded to on a 7-point scale ranging from 
strongly disagree (1) to strongly agree (7) with higher scores indicative of stronger explicit 
identification with drug use. The scale showed good internal reliability at Time 1 (α=.84) 
and Time 2 (α=.85).  
Peer networks 
Research suggests that peer networks are particularly influential on drug use pathways 
(Bryant et al., 2012; Cook, Bauermeister, Gordon-Messer & Zimmerman, 2013; Fuller et 
al., 2005; Treloar et al., 2003). Four questions concerning friends using drugs were 
included in the survey to measure the influence of peer networks on drug use and to 
assess whether implicit and/or explicit identification with drug use predicted variance in 
drug use over and above peer networks. Items were adapted from different studies to best 
reflect the influence of peer networks on drug trajectories. Two of the questions assessed 
association with peers who use drugs, How many of your friends inject drugs at least once 
a month? and How many of your friends use (but do not inject) drugs at least once a 
month (Rice et al., 2005). Responses were provided on a 5-point scale, ranging from none 
of my friends to all of my friends. There was also a two item scale that measured 
perceived support for drug use by peers. Respondents were asked How do you think your 
close friends would feel about you using drugs regularly? and How do you think your close 
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friends would feel about you using drugs occasionally? (Cook et al., 2013). Responses 
were provided with four different response options, which were; don’t know, disapprove, 
neither approve nor disapprove, and approve. This two item scale showed good internal 
reliability at Time 1 (α=.86) and Time 2 (α=.72). 
 
Negative consequences 
Negative consequences of drug use are important to consider because research suggests 
that having been punished for drug use predicts greater future drug use (Kaplan & 
Johnson, 1991; Kaplan & Fukurai, 1992). Two questions were included in the survey that 
measured negative consequences of use of illicit drugs. These two questions assessed 
whether their drug use had ever led to arrest, close calls with police, or trouble with school 
authorities, Have you either had a close call with police or been arrested because of your 
use of drugs? and Have you lost your job or been in trouble on the job because of using 
illegal drugs, or been in trouble with teachers or school authorities because of it?. Each 
item could be answered as no = 0 or yes = 1.  
 
Questions on patterns of drug use  
To measure patterns of drug use, questions around drug of choice, types of drugs used, 
and frequency and recency of use were included in the survey. Participants were asked if 
they had ever, even once, used an illicit substance. The nine participants who responded 
that they have never used illicit substances skipped all further questions concerning 
patterns of drugs use. In order to compare drug-using patterns and behaviour for those 
participants that inject verse those participants that use via other forms of administration 
(smoking, snorting and swallowing), remaining participants were then asked if they had 
ever injected illicit drugs. To measure frequency of drug use, participants were asked In 
the last 12 months, did you use illicit drugs and if so how often?. Responses to this 
question were provided on a 7-point scale ranging from not in the last 12 months to every 
day. To measure recency of drug use, participants were asked When was the last time you 
used illicit drugs?. Responses to this question were provided on a 6-point scale, ranging 
from today to more than 6 months ago.   
Respondents were also asked to report the last drug that they had used from a list of 
substances: Heroin, Cannabis, Cocaine, Ecstasy, Ice, Speed, Ketamine, Benzos, 
Methadone/Bupe, Prescription opioids, Testosterone, Peptides or other. Other was left as 
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an open ended question for them to complete in case the drug last used was not on the 
list. In addition they were asked if they had used any of the above listed drugs in the last 
12 months. Participants could tick as many of these drugs as they had used and once 
again other was left as an open ended question for them to complete. A variable was 
created to measure multiple drug use (the number of different types of drugs used by 
participants) by summing the different drugs the participants reported using in the last 
year.  
Socio-demographic characteristics  
Data were collected on relevant socio-demographic characteristics including: age at time 
of survey (years), age at time of first use (years), gender, years of education, and main 
source of income (see Table 1 above).  
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CHAPTER 4 - Results 
Prior to conducting the main analyses, various sample characteristics were examined. 
These analyses were conducted on the 228 respondents who completed the Time 1 
survey and the 78 respondents who completed the Time 2 survey. The majority of 
respondents used illicit drugs at least once a week or more often (see Table 2). 
Approximately half of the respondents at both time points reported using drugs every day, 
with over 40% reporting using on the day the survey was completed.   
Table 2: Frequency and recency of drug use 
 
 
 
 
 
 
 
 
 
 
 
 
Participants reported cannabis as the primary drug of choice, followed by heroin and 
crystal methamphetamine (see Table 3). Three-quarters of the sample had used cannabis 
in the last 12 months, with over 60% having used crystal methamphetamine, and more 
than a third having used heroin. Twenty-two percent of respondents reported that they had 
used only one drug in the last 12 months, 23% reported they had used 2 or 3 different 
types of drugs, while 43% reported using four or more different illicit substances in the last 
12 months. 
Frequency of use in last 12 months  Time 1 % Time 2 % 
Not in the last 12 months 11.5 5.1 
Once or twice a year 4.4 6.4 
Every few months 5.8 7.7 
About once a month 7.5 7.7 
Once a week or more 25.7 21.8 
Everyday 45.1 51.3 
When was the last time you used drugs? Time 1 % Time 2 % 
Today 41.5 47.4 
Yesterday 26.1 26.3 
Last week 16.9 9.2 
More than a week ago 4.3 7.9 
More than a month ago 5.3 2.6 
More than 6 months ago 5.8 6.6 
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Table 3: Drug of choice 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Social network 
Almost half of the participants reported that most or all of their friends used drugs at least 
once a month, and 29% reporting that most or all of their friends injected at least once a 
month (see Table 4). Approximately half the participants indicated that their friends would 
neither approve nor disapprove of them using regularly and/or occasionally.  
 
 
Drug last used  Time 1 % Time 2 % 
Cannabis 36.7 42.1 
Crystal methamphetamine 24.2 19.7 
Heroin 22.2 27.6 
Prescription opioids 4.8 2.6 
Methadone 2.4 0 
Cocaine 1.9 3.9 
Used the following drug in the last 12 months 
(Categories are not mutually exclusive) 
  
Cannabis 74.9 76.3 
Crystal methamphetamine 65.7 65.8 
Heroin 43 34.2 
Cocaine 28.5 26.3 
Ecstasy  28 30.3 
LSD 20.8 13.2 
Speed 24.6 25 
Ketamine 9.7 6.6 
Benzodiazepines 27.5 28.9 
Methadone 26.6 18.4 
Prescription opioids 29.5 32.9 
Other 12.1 17.1 
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Table 4: Social networks 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Negative Consequences 
Approximately two-thirds of the sample reported being the object of negative social 
sanctions in the form of a close call with police or being arrested because of drug use. 
Over 40% also reported having lost their job or being in trouble on the job or with school 
authorities (see Table 5).   
 
How many of your friends use but do not inject drugs at least 
once a month 
Time 1 % Time 2 % 
none 7.9 7.7 
A few 29.4 32.1 
About half 14.5 12.8 
Most  33.3 32.1 
All 14.9 15.4 
How many of your friends inject drugs at least once a month   
none 22.4 10.3 
A few 34.6 43.6 
About half 14.5 16.7 
Most  21.1 20.5 
All 7.5 9 
How do you think most of your friends would feel about you 
using regularly? 
  
Disapprove 34.2 32.1 
Neither approve nor disapprove 48.7 53.8 
Approve 17.1 14.1 
How do you think most of your friends would feel about you 
using occasionally? 
  
Disapprove 27.6 25.6 
Neither approve nor disapprove 54.8 55.1 
Approve 17.5 19.2 
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Table 5: Negative consequences 
 
 
 
Using on the day of testing 
To investigate the reliability of the IAT with people who have recently used illicit 
substances, analysis was conducted to look at participants’ reaction times on the IAT 
taking into account recency of use. Analyses found that variability in reaction time did not 
differ between those who used drugs on the day of testing and those who had not. The 
fact that no significant differences were found in reaction times (see Table 6), suggests 
that using drugs on the day of testing did not affect the reliability of the test [F(1, 221) = 
.05, p>.05].  
Table 6: IAT Reaction time based on recency of use 
 Mean SD       N F p 
Used drugs on the day of testing  428.623       262.595     85    
Did not use drug son the day of 
testing        
421.037        246.150       138 .05 .828 
 
Study drop out 
Analyses were conducted to determine whether there were systematic differences 
between participants who only completed the study at Time 1 compared to those who 
completed the study across both time points. Time 1 measures of severity of dependence, 
implicit and explicit identification, function of drug use, frequency and recency of drug use, 
and multiple drug use were analysed to assess whether these differed between people 
who completed both testing sessions and those who did not. No significant differences 
were found on most of these variables (see Table 7), suggesting that these factors did not 
play a role in participant drop out. Participants who were using more frequently were, 
however, significantly more likely to be recruited again [F(1, 224) = 11.83, p<.001]. One 
possible reason for this finding is that participants who were using more frequently were 
more likely to be frequenting the same recruitment sites (parks, train stations and NSPs) 
where they were originally surveyed.  
Trouble around drug use Time 1 % Time 2 % 
Had a close call with police /arrested because of drug use 64.8 69.7 
Lost job or trouble on the job or with school authorities 43.2 47.4 
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Table 7: Dropped out vs. retained participants 
 T1 Mean T1 SD       N F p 
SDS (dropped out)  1.121       .758        131    
SDS (retained)        1.259        .777       76 1.57 .211 
      
IAT (dropped out) .022 .526 143   
IAT (retained) -.043 .586 75 .69 .406 
      
Explicit identification (dropped out) 3.821 1.287 148   
Explicit identification (retained) 3.953 1.379 76 .50 .479 
      
Function of use (dropped out) 4.963 1.477 139   
Function of use (retained) 5.127 1.090 74 .71 .400 
      
Frequency of use (dropped out) 4.392 1.817 148   
Frequency of use (retained) 5.192 1.320 78 11.83 .001 
      
Recency of use (dropped out) 2.267 1.523 131   
Recency of use (retained) 2.171 1.341 76 .21 .648 
      
Multiple drug use (dropped out) .335 .240 131   
Multiple drug use (retained) .309 .191 76 .66 .419 
 
As can be seen in Table 8, there was little movement among participants from injecting to 
non-injecting or vice-versa as their main route of administration of illicit substances 
between Time 1 and Time 2. Seven participants changed from injecting at Time 1 to other 
methods of administration at Time 2 and three participants changed from smoking or 
snorting at Time 1 to injecting at Time 2. 
Table 8: Movement from non-injecting to injecting as main route of administration 
  Injecting as main route of administration at Time 2 
 
Injecting as main route of 
administration at Time 1 
 No Yes Total 
No 35 3 38 
Yes 7 33 40 
Total 42 36 78 
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To test the hypothesis that implicit associations between self and drug use would be 
stronger among participants who use harder drugs regularly than those participants who 
use softer drugs recreationally, injecting as main route of administration was analysed to 
see how it relates to the different drug-using variables. Point-biserial correlations revealed 
that implicit and explicit identification with drug use, frequency, multiple drug use, and 
severity of dependence all positively correlated with injecting at Time 1. There was also a 
negative correlation between recency of drug use and injecting (more recent use of drugs 
was given a lower score in the survey). Taken together this finding indicates that 
participants who were injecting were more likely to be habitual users of drugs (measured 
by frequency, recency, multiple use, and severity of use) and have greater implicit and 
explicit identification with their drug use at Time 1 (see Table 9). These findings suggest 
that these measures of identification are tracking drug use behaviour in the expected 
direction. However, this pattern was not found with the smaller sample at Time 2, with the 
exception of a significant positive correlation between multiple drug use and injecting at 
Time 2.   
 
 Table 9: Point-biserial correlation with injecting as main route of administration  
 Injecting Time 1 Injecting Time 2 
IAT  .229
***
 .180 
Explicit  .403
***
 .163 
Frequency   .303
***
 .156 
Recency  -.248
***
 -.130 
Multiple drug use .308
***
 .306
**
 
Severity of dependence .336
***
 .204 
  
To investigate the bivariate relationships among all of the variables, correlations were 
conducted to examine relationships at Time 1 (see Table 10) and Time 2 (see Table 11). 
For the purpose of this study, more serious drug use was seen to be a combination of 
three variables; frequency, recency, and multiple drug use. In order words, participants 
who used more frequently and recently and who reported using two or more drugs over a 
sustained period of time were seen as using drugs more seriously. As can be seen in 
these tables, seriousness of drug use was significantly correlated with several other 
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variables. Participants who used drugs more often were more likely to be injecting as a 
main route of administration and to show greater severity of dependence. This finding 
supports existing research that suggests that as dependence on drugs increases and as 
people transition to harder drugs and injecting, so too does the need to use drugs more 
regularly (Gossop et al., 1992).   
People who used drugs more frequently were found to have significantly more friends who 
were using and injecting. This finding supports research discussed in chapter one that 
suggests that peer networks are particularly influential in the decision for most young 
people to use drugs and that drug use often takes place in social settings (Bryant et 
al.,2012; Fuller et al., 2003, 2005; Treloar et al., 2003). Further, previous literature has 
shown that using drugs to improve depressed moods and/or for social purposes is 
associated with frequency of drug use (Boys et al., 2001). Consistent with these findings, 
participants who used drugs more frequently were more likely to report using drugs for 
positive social interaction and mood enhancements. Using drugs at a younger age was 
also associated with using more frequently. This finding supports literature that suggests 
that age of first drug use is a powerful predictor of lifetime drug dependence (Loxley et al., 
2004; Obot et al., 2001; Toumbourou & Catalano; 2005). Participants who used more 
seriously also reported encountering significantly more negative consequences (Kaplan & 
Johnson, 1991) and showed increased severity of dependence on their drug use (Gossop 
et al., 1992, 1995), both of which are consistent with prior research. In addition, significant 
correlations between explicit and implicit identification with the three variables that 
represent seriousness of drug use suggests that patterns of drug use are tied up with the 
identity of the individual and may be a significant predictor of movement from occasional to 
regular drug use.  
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Table 10: Correlations at Time 1 
Time 1 Frequency Recency Multiple 
drug use 
SDS  Explicit ID Implicit ID Function of 
use 
Friends use Friends inject Perceived peer 
support 
Education Income Age Age first use Negative social 
sanctions 
Gender 
Recency -.536***                
Multiple drug 
use 
.304*** -.319***               
SDS  .312*** -.283*** .310***              
Explicit ID .506*** -.430*** .423*** .419***             
Implicit ID .052 -.204** .220** .175* .176**            
Function  .362*** -.284*** .267*** .348*** .569*** .098           
How many 
friends use but 
do not inject  
.225*** -.099 .211** .139* .335*** .134* .386***          
How many 
friends inject 
drugs 
.360*** -.241*** .186** .225*** .470*** .249*** .301*** .305***         
Perceived peer 
support 
.122 .009 -.057 -.098 .295*** .085 .287*** .339*** .251***        
Education -.077 -.002 .068 -.007 -.143* -.090 .009 -.051 -.177** -.219***       
Income .083 -.033 .078 .024 .169* -.028 .153* -.148* .161* .159* -.091      
Age .167* -.172* .211** .261*** .226*** .242*** .011 -.135* .212*** -.106 -.013 -.006     
Age first use -.374*** .095 -.036 -.110 .332*** -.081 -.135* -.105 -.166* -.119 .106 -.176** -.160*    
Negative 
consequences 
.144* -.185** .269*** .342*** .371*** .156* .234*** .018 .349*** .012 -.081 .007 .165* -.131   
Gender  -.115 -.018 -.118 .104 -.021 .073 -.048 .084 -.020 .042 .132 .074 -.126 .062 -.182**  
Injecting as main 
route
2
 
.303*** -.248*** .308*** .336*** .403*** .229*** .200*** -.090 .396*** -.119 -.013 .096 .499*** -.193 .263*** .095 
 
1
Transgender and unisex were excluded from gender analyses. Point-biserial correlations used to examine relationships between other variables and gender 
2
Point-biserial correlations used to examine relationships between other variables and injecting 
*     Correlation is significant at the 0.05 level (2 tailed) 
**   Correlation is significant at the 0.01 level (2 tailed)  
*** Correlation is significant at the 0.001 level (2 tailed) 
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Table 11: Correlations at Time 2 
Time 2 Frequency Recency Multiple 
drug use 
SDS  Explicit ID 
 
Implicit ID 
 
Function of 
use 
 
Friends use Friends inject Perceived peer 
support 
Education Income Age Age first use Negative social 
sanctions 
Gender 
Recency -.553***                
Multiple drug 
use 
.337** -.290*               
SDS  .113 -.102 .175              
Explicit ID .440*** .513*** 
 
.359*** .347**             
Implicit ID .320** .453*** .048 .200 .272*            
Function of use 
 
.427*** .222 .136 .287* .412*** .329**           
How many 
friends use but 
do not inject  
.399*** -.189 .123 -.211 .133 .108 .179          
How many 
friends inject 
drugs 
.386*** -.295** .158 -.007 .421*** .249* .140 .232*         
Perceived peer 
support 
.289* -.095 -.127 -.062 .174 .172 .194 .291** .276*        
Education .243* .011 .234* .138 -.015 -.079 .116 .004 -.055 -.007       
Income .102 -.037 .100 .132 -.081 .099 .045 -.034 .019 .028 -.185      
Age -.060 -.138 .029 .208 .222 .100 -.109 -.231* .128 -.218 -.012 -.035     
Age first use -.293** .213 -.173 .193 -.252* -.102 -.001 -.186 -.186 -.131 -.007 .008 .042    
Negative social 
sanction 
.048 -.148 .26* .343** .445*** .099 .258* -.178 .180 -.048 -.156 .032 .218 -.238*   
Gender1 -.175 .262* -.145 -.055 -.149 -.216 -.039 -.263* -.149 -.056 -.029 .010 .219 -.044 .095  
Injecting as main 
route 
.156 -.130 .306** .204 .163 .180 .047 -.177 .183 -.291** .245* -.102 .418*** -.049 .188 -.072 
1
Transgender and unisex were excluded from gender correlation. Point-biserial correlations used to examine relationships between other variables and gender. 
2
Point-biserial correlations used to examine relationships between other variables and injecting. 
*     Correlation is significant at the 0.05 level (2 tailed) 
**   Correlation is significant at the 0.01 level (2 tailed)  
*** Correlation is significant at the 0.001 level (2 tailed)
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The relationships that exist between frequency/recency of use/multiple drug use and 
implicit/explicit identification in Tables 10 and 11 suggests that these identity variables 
might play a role in whether drug use increases or decreases in seriousness over time. As 
a first step in testing this possibility, correlations between Time 1 and Time 2 variables 
were examined. 
According to predictions, identification with drug use should predict greater frequency and 
recency of drug use over time (see Table 12). The results of Table 12 suggest that explicit 
identification is associated with greater frequency, recency and multiple drug use, and that 
frequency and recency of use at Time 1 is associated with greater explicit identification at 
Time 2. Finally, multiple drug use at Time 1 is associated with greater implicit and explicit 
identification at Time 2. 
Table 12: Longitudinal correlations across Time 1 and Time 2 variables 
 Frequency 
Time 1 
Recency 
Time 1 
Multiple drug 
use Time1 
SDS  
time1 
Function of  
use Time1 
Explicit ID 
Time1 
Implicit ID    
Time1 
Frequency  
Time2 
.587
***
 -.352
**
 .189 .063 .242
*
 .427
***
 .062 
Recency  
Time2 
-.241
*
 .435
***
 -.340 
***
 -.127 -.252
*
 -.379
***
 -.128 
Multiple drug  
use Time2 
.231
*
 -.263
*
 .604
***
 .071 .212 .404
***
 .015 
SDS  
Time2 
.141 -.122 .250
*
 .454
***
 
 
.361
**
 .286
*
 .199 
Function  
Time2 
.342
**
 -.153 .127 .184 .515
***
 .285
*
 .161 
Explicit 
ID Time2 
.326
**
 -.336
**
 .397
***
 .268
*
 .457
***
 .662
***
 .216 
Implicit ID  
Time2 
.050 -.129 .235
*
 .011 .258
*
 .170 .114 
 
Longitudinal regression analyses 
To test the hypothesis that participants who showed a strong implicit association between 
self and drug use would develop more serious drug use, regression analyses were 
conducted to predict frequency, recency and multiple drug use. 
To test the possibility that a strong implicit association between self and drug use at Time 
1 would lead to increased frequency of drug use at Time 2, frequency of use at Time 2 
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was regressed on frequency of use at Time 1 in the first step of the model. In the second 
step of the model implicit and explicit identification were added as predictors. Neither 
implicit nor explicit identification predicted frequency of use at Time 2 after controlling for 
frequency of use at Time 1, and so these paths are left out of the model. As expected, 
frequency of use at Time 1 predicted frequency of use at Time 2. 
To test the hypothesis that frequency of drug use would lead to stronger implicit and 
explicit identification with drug use over time, implicit and explicit identification at Time 2 
were regressed on implicit and explicit identification at Time 1 in step 1, and frequency of 
use was added as a predictor in the second step of the model. As can be seen in Figure 1, 
explicit identification at Time 1 predicted explicit identification at Time 2, but implicit 
identification at Time 1 did not predict implicit identification at Time 2. Furthermore, 
frequency of use did not account for independent variance in either implicit or explicit 
identification (and so these paths are left out of the model). Tables 13, 14, and 15 report 
the coefficients from these longitudinal analyses with frequency of use. 
Figure 3: Frequency of drug use across time 
 
 
 
.61*** 
.69*** 
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Table 13: Frequency of use at Time 2 
 Beta t p 
Frequency at Time 1 .606 5.695 .000 
Explicit identification at Time 1 .084 .777 .449 
IAT Time 1 .084 .896 .373 
 
Table 14: Explicit identification at Time 2 
 Beta t p 
Explicit identification at Time 1 .686 6.850 .000 
IAT Time 1 .091 1.048 .298 
Frequency at Time 1 .020 .200 .842 
 
Table 15: Implicit identification at Time 2 
 Beta t p 
IAT at Time 1 .110 .897 .373 
Explicit identification Time 1 .168 1.174 .245 
Frequency at Time 1 .009 .065 .948 
 
Similarly, to test the possibility that a strong implicit association between self and drug use 
would lead to increased recency of drug use, in the first step of the model recency of use 
at Time 2 was regressed on recency of use at Time 1. In the second step of the model 
implicit and explicit identification were added as predictors. Neither explicit identification 
nor implicit identification predicted recency of use at Time 2 after controlling for recency at 
Time 1, so these paths are again left out of the model. 
To test the hypothesis that recency of drug use would be associated with stronger implicit 
and explicit identification with drug use over time, further regression analyses were 
conducted. Implicit and explicit identification at Time 2 were regressed on implicit and 
explicit identification at Time 1 in step 1, and recency of use was added as a predictor in 
the second step of the model. As can be seen in Figure 2, recency of use did not account 
for independent variance in either implicit or explicit identification (and so these paths are 
left out the model). Tables 16, 17 and 18 report the coefficients from these longitudinal 
analyses with recency of use. 
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Figure 4: Recency of use across time 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 16: Recency of use at Time 2 
 Beta t p 
Recency at Time 1 .324 2.490 .015 
Explicit identification at Time 1 -.239 -1.874 .065 
IAT Time 1 .019 .165 .870 
 
 Table 17: Explicit identification at Time 2 
 Beta t p 
Explicit identification at Time 1 .640 6.463 .000 
IAT Time 1 .073 .809 .421 
Recency at Time 1 -.102 -1.007 .318 
 
Table 18: Implicit identification at Time 2 
 Beta t p 
IAT at Time 1 .023 .180 .858 
Explicit identification Time 1 .098 .679 .500 
Recency at Time 1 -.166 -1.095 .278 
 
 
 
.32* 
.64*** 
.02 
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To test the possibility that a strong implicit association between self and drug use would 
lead to an increase in multiple drug use, in the first step of the model multiple drug use at 
Time 2 was regressed on multiple drug use at Time 1. In the second step of the model 
implicit and explicit identification were added as predictors. Neither implicit nor explicit 
identification predicted multiple drug use at Time 2 after controlling for multiple drug use at 
Time 1, so these paths are left out of the model. 
To test the hypothesis that multiple drug use would lead to stronger implicit and explicit 
identification with drug use over time, implicit and explicit identification at Time 2 were 
regressed on implicit and explicit identification at Time 1 in step 1, and multiple drug use 
was added as a predictor in the second step of the model. As can be seen in Figure 3, 
multiple drug use did not account for independent variance in either implicit or explicit 
identification (and so these paths are left out the model). Tables 18, 19 and 20 report the 
coefficients from these longitudinal analyses with report the coefficients from these 
longitudinal analyses with multiple drug use. 
 
Figure 5: Multiple drug use across time 
 
 
#Drugs = Number of different types of drug used 
(higher #’s = more different types of drugs used) 
 
 
.03 
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Table 19: Multiple drug use at Time 2 
 Beta t p 
Multiple drug use at Time 1 .582 5.581 .000 
IAT at Time 1 .189 1.825 .072 
Explicit identification Time 1 -.119 -1.222 .226 
 
Table 20: Explicit identification at Time 2 
 Beta t p 
Explicit identification at Time 1 .656 6.943 .000 
IAT at Time 1 .078 .876 .384 
Multiple drug use at time 1 .086 .898 .373 
 
Table 21: Implicit identification at Time 2 
 Beta t p 
IAT at Time 1 .029 .234 .816 
Explicit identification at Time 1 .106 .802 .426 
Multiple drug use at Time 1 .199 1.486 .142 
 
Subsidiary analyses 
As can be seen in Tables 10 and 11, the IAT is correlated with recency of use and multiple 
drug use at Time 1 and frequency and recency of use at Time 2, but it is not clear whether 
the IAT predicts unique variance after controlling for explicit identification. To assess 
whether the IAT predicts unique cross-sectional variance in frequency of use, frequency 
was regressed simultaneously on the IAT and explicit identification, separately at Time 1 
(see Table 22) and Time 2 (see Table 23). The Time 2 analyses also included the Time 1 
indicator of frequency in the first step of the model.  
Similarly, to assess whether the IAT predicts unique variance in recency of use, recency 
was regressed simultaneously on the IAT and explicit identification, separately at Time 1 
(see Table 24) and Time 2 (see Table 25). The Time 2 analyses also included the Time 1 
indicator of recency in the first step of the model. Lastly, to assess whether the IAT 
predicts unique variance in multiple drug use, multiple drug use was regressed 
simultaneously on the IAT and explicit identification, separately at Time 1 (see Table 26) 
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and Time 2 (see Table 27). The Time 2 analyses also included the Time 1 indicator of 
multiple drug use in the first step of the model. 
 
As can be seen in Tables 22-27, these analyses revealed that the IAT predicted unique 
variance in recency and multiple drug use at Time 1. Explicit identification predicted unique 
variance in all three variables at Time 1. At Time 2, both explicit and implicit identification 
predicted independent variance in recency and frequency of use, although neither 
predicted independent variance in multiple drug use at Time 2.  
 
Table 22: Frequency of use at Time 1 
 Beta t p 
IAT at Time 1 -.028 -.465 .643 
Explicit identification at Time 1 .525 8.794 .000 
 
Table 23: Frequency of use at Time 2 
 Beta t p 
Frequency at Time 1 .526 5.961 .000 
IAT at Time 2 .229 2.653 .010 
Explicit identification at Time 2 .237 2.582 .012 
 
Table 24: Recency at Time 1 
 Beta t p 
IAT at Time 1 -.156 -2.422 .016 
Explicit identification at Time 1 -.423 -6.588 .000 
 
Table 25: Recency at Time 2 
 Beta t p 
Recency at Time 1  .266 2.733 .008 
IAT at Time 2 -.325 -3.432 .001 
Explicit identification at Time 2 -.337 -3.337 .001 
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Table 26: Multiple drug use at Time 1 
 Beta t p 
IAT at Time 1 .172 2.664 .008 
Explicit identification at Time 1 .423 6.229 .000 
 
 
Table 27: Multiple drug use at Time 2 
 Beta t p 
Multiple drug use at Time 1  .552 5.263 .000 
IAT at Time 2 -.119 -1.182 .241 
Explicit identification at Time 2 .177 1.671 .099 
 
To assess whether these relationships between the identification variables and frequency 
and recency of use, and multiple drug use, might be accounted for by other variables, 
recency, frequency, and multiple drug use were each regressed simultaneously on the 
identification variables and each control variable separately at Time 1 and Time 2.  
No relationship was found between implicit identification and frequency at Time 1.  
At Time 2, to assess what might account for the relationship between implicit identification 
and frequency of use at Time 2, the Time 1 indicator of frequency was included in the first 
step of the model together with the previously used variables. The number of friends that 
use but do not inject at least once a month at Time 2 and function of use at Time 2 were 
found to have a significant effect on the frequency of drug use. These significant variables 
were then entered into the same equation, to see if implicit identification can predict unique 
variance in frequency of use beyond these significant alternatives, while still controlling for 
frequency at Time 1. The findings suggest that while these two other predictor variables 
have a significant effect on drug use frequency, they are not able to predict unique 
variance in drug use frequency over and above implicit identification (see Table 28). 
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Table 28: Frequency with implicit identification at Time 2 
 Beta t p 
Frequency at Time 1 .551 5.581 .000 
SDS at Time 2 -.001 -.009 .993 
IAT at Time 2 .271 2.715 .008 
    
Frequency at Time 1 .439 4.278 .000 
Function of use at Time 2 .242 2.227 .029 
IAT at Time 2 .218 2.135 .036 
    
Frequency at Time 1 .555 6.698 .000 
Number of friends that use but do not inject at least 
once a month at Time 2 
.263 3.158 .002 
IAT at Time 2 .264 3.223 .002 
    
Frequency at Time 1 .554 6.278 .000 
Number of friends that inject at least once a month 
at Time 2 
.178 1.954 .055 
IAT at Time 2 .248 2.839 .006 
    
Frequency at Time 1 .592 6.414 .000 
Negative social sanctions at Time 1 -.043 -.459 .648 
IAT at Time 2 .280 3.068 .003 
    
Frequency at Time 1 .603 6.966 .000 
Age at Time 2 -.070 -.808 .422 
IAT at Time 2 .297 3.412 .001 
    
Frequency Time 1 .583 6.209 .000 
Age of first use at Time 2 -.051 -5.44 .588 
IAT at Time 2 .286 3.278 .002 
    
    
44 
Frequency at Time 1 .606 7.080 .000 
Gender at Time 2 -.135 -1.545 .127 
IAT at Time 2 .261 2.973 .004 
    
Frequency at Time 1 .571 6.534 .000 
Education at Time 2 .148 1.697 .094 
IAT at Time 2 .303 3.541 .001 
    
Frequency at Time 1 4.33 4.408 .000 
Number of friends that use but do not inject at least 
once a month at Time 2 
.250 2.718 .008 
Function of use at Time 2 .198 1.886 .064 
IAT at Time 2 .209 2.145 .036 
 
Similarly, with regard to recency of drug use at Time 1, the same variables that might 
account for the relationship between implicit identification and recency of use were entered 
into a regression analysis separately. Several of the control variables were again found to 
have an effect on recency of use. Severity of dependence of drug use, function of use, the 
number of friends that inject drugs and negative social sanctions were found to have a 
significant effect on recency of drug use. An additional regression analysis was conducted 
to see if implicit identification would still be significant when simultaneously controlling for 
the above variables that emerged as significant predictors in the model. Implicit 
identification was not found to be meaningfully related with recency at Time 1 over and 
above severity of dependence and function of use (see Table 29).  
Table 29: Recency with implicit identification at Time 1 
 Beta t p 
SDS at Time 1 -.267 -3.895 .000 
IAT at Time 1 -.157 -2.293 .023 
    
Function of use at Time 1 -.264 -3.837 .000 
IAT at Time 1 -.172 -2.501 .013 
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Number of friends that use but do not inject at least 
once a month at Time 1 
-.086 -1.230 .220 
IAT at Time 1 -.192 -2.740 .007 
    
Number of friends that inject at least once a month 
at Time 1 
-.208 -2.942 .004 
IAT at Time 1 -.153 -2.162 .032 
    
Negative social sanctions at Time 1 -.193 -2.781 .006 
IAT at Time 1 -.175 -2.527 .012 
    
Age at Time 1 -.108 -1.497 .136 
IAT at Time 1 -.176 -2.438 .016 
    
Age at first use at Time 1 .102 1.468 .144 
IAT at Time 1 -.206 -2.960 .003 
    
Gender at Time 1 -.021 -.292 .770 
IAT at Time 1 -.203 -2.824 .005 
    
Education at Time 1 -.001 -.015 .988 
IAT at Time 1 -.204 -2.906 .004 
    
SDS at Time 1 -.163 -2.161 .032 
Function of use at Time 1 -.169 -2.301 .023 
Number of friends that inject at least once a month 
at Time 1 
-.107 -1.418 .158 
Negative social sanctions at Time 1 -.060 -.794 .428 
IAT at Time 1 -.118 -1.686 .093 
 
To assess what might account for the relationship between implicit identification and 
recency of use at Time 2, the Time 1 indicator of recency was included in the first step of 
the model together with all the other variables at Time 2. Only gender was found to also 
have a significant effect on recency of drug use over time. However, when controlling for 
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gender, implicit identification was still found to be meaningfully related to recency of use at 
Time 2 (see Table 30). 
Table 30: Recency with implicit identification at Time 2 
 Beta t p 
Recency at Time 1 .349 3.361 .001 
SDS at Time 2 .021 .202 .840 
IAT at Time 2 -.400 -3.802 .000 
    
Recency at Time 1 .342 3.274 .002 
Function of use at Time 2 -.066 -.597 .552 
IAT at Time 2 -.379 -3.489 .001 
    
Recency at Time 1 .387 4.014 .000 
Number of friends that use but do not inject at least 
once a month at Time 2 
-.181 -1.881 .064 
IAT at Time 2 -.389 -4.020 .000 
    
Recency at Time 1 .348 3.510 .001 
Number of friends that inject at least once a month at 
Time 2 
-.148 -1.452 .151 
IAT at Time 2 -.375 -3.758 .000 
    
Recency at Time 1 .399 3.691 .000 
Negative social sanctions at Time 2 .051 .474 .637 
IAT at Time 2 -.411 -4.169 .000 
    
Recency at Time 1 .376 3.749 .000 
Age Time 2 -.014 -.137 .891 
IAT at Time 2 -.407 -4.096 .000 
    
Recency at Time 1 .361 3.645 .001 
Age of first use at Time 2 .107 1.081 .284 
IAT at Time 2 -.399 -4.062 .000 
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Similarly, with regard to multiple drug use at Time 1, the same variables that might account 
for the relationship between implicit identification and multiple drug use were entered into a 
regression analysis separately. Several of the control variables were again found to have 
an effect on number of different drugs used. Severity of dependence of drug use, function 
of use, the number of friends that use drugs and the number of friends that inject drugs, 
negative social sanctions and the age of participant at the time of the survey were also 
found to have a significant effect on multiple drug use. When controlling for these variables 
that emerged as predictors of multiple drug use at Time1, only age at the time of the 
survey and the number of friends that use drugs were still found to have a significant effect 
on multiple drug use (see Table 31).  
Table 31: Multiple drug use with implicit identification at Time 1 
    
Recency at Time 1 .413 4.299 .000 
Gender at Time 2 .231 2.364 .021 
IAT at Time 2 -.353 -3.615 .001 
    
Recency at Time 1 .377 3.821 .000 
Education at Time 2 -.033 -.340 .735 
IAT at Time 2 -.412 -4.158 .000 
 Beta t p 
SDS at Time 1 .276 4.057 .000 
IAT at Time 1 .172 2.527 .012 
    
Function of use at Time 1 .248 3.609 .000 
IAT at Time 1 .198 2.875 .005 
    
Number of friends that use but do not inject at least 
once a month at Time 1 
.185 2.676 .008 
IAT at Time 1 .196 2.842 .005 
    
Number of friends that inject at least once a month 
at Time 1 
.147 2.072 .040 
IAT at Time 1 .184 2.587 .010 
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Once again, to assess what might account for the relationship between implicit 
identification and multiple drug use at Time 2, the Time 1 indicator of multiple drug use 
was included in the first step of the model together with all the other variables at Time 2. 
No variables were found to have a significant effect on multiple drug use over time (see 
Table 32). 
Table 32: Multiple drug use with implicit identification at Time 2 
    
Negative social sanctions at Time 1 .233 3.401 .001 
IAT at Time 1 .186 2.714 .007 
    
Age at Time 1 .178 2.501 .013 
IAT at Time 1 .174 2.447 .015 
    
Age at first use at Time 1 -.040 -.569 .570 
IAT at Time 1 .221 3.173 .002 
    
Education at Time 1 .063 .908 .365 
IAT at Time 1 .225 3.223 .001 
    
SDS at Time 1 .135 1.753 .081 
Function of use at Time 1 .124 1.644 .102 
Number of friends that use but do not inject at least 
once a month at Time 1 
.177 2.355 .020 
Number of friends that inject at least once a month 
at Time 1 
-.034 -.445 .657 
Negative social sanctions at Time 1 .147 1.966 .051 
Age at Time 1 .159 2.142 .033 
IAT at Time 1 .113 1.607 .110 
 Beta t p 
Multiple drug use at Time 1 .588 5.693 .000 
SDS at Time 2 .056 .546 .587 
IAT at Time 2 -.103 -1.016 .313 
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These analyses were repeated to assess whether the relationships between explicit 
identification variables and frequency, recency of use and multiple drug use might also be 
accounted for by other variables.  
    
Multiple drug use at Time 1 .585 5.698 .000 
Function of use at Time 2 .081 .766 .447 
IAT at Time 2 -.112 -1.047 .299 
    
Multiple drug use at Time 1 .617 6.249 .000 
Number of friends that use but do not inject at least 
once a month at Time 2 
.131 1.358 .179 
IAT at Time 2 -.097 -.975 .333 
    
Multiple drug use at Time 1 .612 6.219 .000 
Number of friends that inject at least once a month at 
Time 2 
.149 1.510 .136 
IAT at Time 2 -.119 -1.177 .243 
    
Multiple drug use at Time 1 .600 5.489 .000 
Negative social sanctions at Time 2 .032 .297 .767 
IAT at Time 2 -.083 -.826 .412 
    
Multiple drug use at Time 1 .617 6.151 .000 
Age Time 2 -.036 -.366 .715 
IAT at Time 2 -.078 -.777 .440 
    
Multiple drug use at Time 1 .559 5.914 .000 
Age of first use at Time 2 -.074 -.744 .459 
IAT at Time 2 -.087 -.873 .386 
    
Multiple drug use at Time 1 .594 6.025 .000 
Education at Time 2 .163 1.690 .096 
IAT at Time 2 -.062 -.623 .535 
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At Time 1, the same nine variables that might account for the relationship between explicit 
identification and frequency of use were entered into separate regression analyses. 
Severity of dependence, function of use, number of friends that inject and age of first use 
were again found to have a significant effect on frequency of drug use at Time 1. These 
variables that emerged as predictors of frequency at Time1, were entered into an 
additional regression analysis. Explicit identification was still found to be meaningfully 
related to frequency at Time 1 even when simultaneously controlling for these other 
predictor variables (see Table 33). At Time 2, the Time 1 indicator of frequency of use was 
again included in the first step of the model separately. Function of use, number of friends 
that use but do not inject and negative social sanctions were found to have a significant 
effect on frequency of use. The findings however suggest that while several of these 
predictor variables once again have a significant effect on frequency of drug use, none of 
them predicted unique variance in drug use frequency over and above explicit 
identification (see Table 34). 
Table 33: Frequency with explicit identification at Time 1 
 Beta t p 
SDS at Time 1 .183 2.600 .010 
Explicit identification at Time 1 .321 4.561 .000 
    
Function of use at Time 1 .188 2.499 .013 
Explicit identification at Time 1 .309 4.112 .000 
    
Number of friends that use but do not inject at least 
once a month at Time 1 
.067 1.093 .275 
Explicit identification at Time 1 .484 7.895 .000 
    
Number of friends that inject at least once a month 
at Time 1 
.162 2.502 .013 
Explicit identification at Time 1 .432 6.675 .000 
    
Negative social sanctions at Time 1 -.022 -.331 .741 
Explicit identification at Time 1 .456 6.799 .000 
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Age Time 1 .057 .950 .343 
Explicit identification at Time 1 .494 8.284 .000 
    
Age of first use at Time 1 -.240 -4.063 .000 
Explicit identification at Time 1 .432 7.306 .000 
    
Gender at Time 1 -.090 -1.535 .126 
Explicit identification at Time 1 .511 8.686 .000 
    
Education at Time 1 .008 .132 .895 
Explicit identification at Time 1 .507 8.606 .000 
    
SDS at Time 1 .147 2.042 .043 
Function of use at Time 1 .177 2.289 .023 
Number of friends that inject at least once a month 
at Time 1 
.110 1.553 .122 
Age of first use at Time 1 -.013 -.196 .845 
Explicit identification at Time 1 .175 2.083 .039 
 
Table 34: Frequency with explicit identification at Time 2 
 Beta t p 
Frequency at Time 1 .417 4.210 .000 
SDS at Time 2 -.070 -.686 .495 
Explicit identification at Time 2 .360 3.438 .001 
    
Frequency at Time 1 .357 3.465 .001 
Function of use at Time 2 .221 2.011 .048 
Explicit identification at Time 2 .204 1.924 .058 
    
Frequency at Time 1 .456 5.160 .000 
Number of friends that use but do not inject at least 
once a month at Time 2 
.288 3.418 .001 
Explicit identification at Time 2 .253 2.883 .005 
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Frequency at Time 1 .473 5.078 .000 
How many friends inject at least once a month at 
Time 2 
.173 1.785 .078 
Explicit identification at Time 2 .213 2.146 .035 
    
Frequency at Time 1 .471 5.135 .000 
Negative social sanctions at Time 2 -.225 -2.314 .024 
Explicit identification at Time 2 .426 4.233 .000 
    
Frequency at Time 1 .488 5.246 .000 
Age at Time 2 -.135 -1.495 .139 
Explicit identification at Time 2 .311 3.260 .002 
    
Frequency at Time 1 .484 4.858 .000 
Age of first use at Time 2 -.037 -.384 .702 
Explicit identification at Time 2 .273 2.867 .005 
    
Frequency at Time 1 .506 5.458 .000 
Gender at Time 2 -.142 -1.603 .113 
Explicit identification at Time 2 .254 2.706 .008 
    
Frequency at Time 1 .461 4.870 .000 
Education at Time 2 .153 1.709 .092 
Explicit identification at Time 2 .292 3.148 .002 
    
Frequency at Time 1 .314 3.053 .003 
Function of use at Time 2 .155 1.488 .141 
Number of friends that use but do not inject at least 
once a month at Time 2 
.282 2.920 .005 
Negative social sanctions at Time 2 -.168 -1.588 .117 
Explicit identification at Time 2 .313 2.837 .006 
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Similarly, the same nine variables that might account for the relationship between explicit 
identification and recency of use were entered into a regression analysis separately at 
Time 1. Only explicit identification was found to have a significant effect on the recency of 
drug use at Time 1 (see Table 35). At Time 2, the Time 1 indicator of recency of use was 
included in the first step of the model separately. Gender was also found to have a 
significant effect on recency of use at Time 2. The findings suggest that no other variable 
predicted unique variance in recency of use over and above explicit identification (see 
Table 36). 
Table 35: Recency with explicit identification at Time 1 
 Beta t p 
SDS at Time 1 -.128 -1.843 .067 
Explicit identification at Time 1 -.37 -5.401 .000 
    
Function of use at Time 1 -.083 -1.076 .283 
Explicit identification at Time 1 -.371 -4.839 .000 
    
Number of friends that use but do not inject at least 
once a month at Time 1 
.018 .276 .783 
Explicit identification at Time 1 -.435 -6.563 .000 
    
Number of friends that inject at least once a month 
at Time 1 
-.083 -1.197 .233 
Explicit identification at Time 1 -.396 -5.695 .000 
    
Negative social sanctions at Time 1 -.046 -.675 .501 
Explicit identification at Time 1 -.414 -6.084 .000 
    
Age at Time 1 -.097 -1.509 .133 
Explicit identification at Time 1 -.413 -6.390 .000 
    
Age of first use at Time  .029 .455 .650 
Explicit identification at Time 1 -.426 -6.597 .000 
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Gender at Time 1 -.026 -.394 .694 
Explicit identification at Time 1 -.445 -6.870 .000 
    
Education at Time 1 -.066 -1.021 .309 
Explicit identification at Time 1 -.439 -6.835 .000 
 
Table 36: Recency with explicit identification at Time 2 
 Beta t p 
Recency at Time 1 .246 2.326 .023 
SDS at Time 2 .082 -.596 .555 
Explicit identification at Time 2 -.442 -3.951 .000 
    
Recency at Time 1 .258 2.424 .018 
Function of use at Time 2 -.013 -.114 .910 
Explicit identification at Time 2 -.392 -3.333 .001 
    
Recency at Time 1 .313 3.096 .003 
Number of friends that use but do not inject at least 
once a month at Time 2 
-.164 -1.713 .091 
Explicit identification at Time 2 -.386 -3.798 .000 
    
Recency at Time 1 .290 2.838 .006 
Number of friends that inject at least once a month at 
Time 2 
-.086 -.812 .419 
Explicit identification at Time 2 -.378 -3.418 .001 
    
Recency at Time 1 .353 3.370 .001 
Negative social sanctions at Time 2 .209 1.897 .062 
Explicit identification at Time 2 -.485 -4.522 .000 
    
Recency at Time 1 .294 2.845 .006 
Age at Time 2 -.007 -.070 .945 
Explicit identification at Time 2 -.411 -3.955 .000 
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Once again, the same nine variables that might account for the relationship between 
explicit identification and multiple drug use were entered into a regression analysis 
separately at Time 1. Severity of dependence, negative social sanctions and age of 
participant at the time the survey were found to have a significant effect on multiple drug 
use. The findings however suggest that while several of these predictor variables once 
again have a significant effect on multiple drug use at Time 1, none of them predicted 
unique variance in drug use over and above explicit identification (see Table 37). At Time 
2, the Time 1 indicator of multiple drug use was included in the first step of the model 
separately. No variables were found to have a significant effect on multiple drug use at 
Time 2 (see Table 38). 
Table 37: Multiple drug use with explicit identification at Time 1 
 Beta t p 
SDS at Time 1 .161 2.312 .022 
Explicit identification at Time 1 .355 5.104 .000 
    
Function of use at Time 1 .061 .800 .425 
Explicit identification at Time 1 .385 5.008 .000 
    
Number of friends that use but do not inject at least 
once a month at Time 1 
.104 1.578 .116 
Explicit identification at Time 1 .394 5.959 .000 
    
Recency at Time 1 .286 2.788 .007 
Age of first use at Time 2 .077 .777 .440 
Explicit identification at Time 2 -.398 -3.832 .000 
    
Recency at Time 1 .342 3.428 .001 
Gender at Time 2 .247 2.609 .011 
Explicit identification at Time 2 -.358 -3.576 .001 
    
Recency at Time 1 .295 2.870 .005 
Education at Time 2 .009 .093 .926 
Explicit identification at Time 2 -.412 -4.014 .000 
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Number of friends that inject at least once a month 
at Time 1 
.018 .259 .796 
Explicit identification at Time 1 .416 5.927 .000 
    
Negative social sanctions at Time 1 .138 2.042 .042 
Explicit identification at Time 1 .374 5.529 .000 
    
Age at Time 1 .149 2.313 .022 
Explicit identification at Time 1 .396 6.153 .000 
    
Age of first use at Time  .029 .451 .652 
Explicit identification at Time 1 .427 6.596 .000 
    
Education at Time 1 .122 1.904 .058 
Explicit identification at Time 1 .439 6.854 .000 
    
SDS at Time 1 .111 1.543 .124 
Negative social sanctions at Time 1 .099 1.441 .151 
Age at Time 1 .116 1.767 .079 
Explicit identification at Time 1 .320 4.491 .000 
 
Table 38: Multiple drug use with explicit identification at Time 2 
 Beta t p 
Multiple drug use at Time 1 .535 5.122 .000 
SDS at Time 2 .004 .038 .970 
Explicit identification at Time 2 .133 1.232 .222 
    
Multiple drug use at Time 1 .534 5.156 .000 
Function of use at Time 2 .002 .020 .984 
Explicit identification at Time 2 .136 1.192 .237 
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Multiple drug use at Time 1 .551 5.446 .000 
Number of friends that use but do not inject at least 
once a month at Time 2 
.089 .949 .346 
Explicit identification at Time 2 .132 1.295 .199 
    
Multiple drug use at Time 1 .552 5.415 .000 
Number of friends that inject at least once a month at 
Time 2 
.057 .549 .585 
Explicit identification at Time 2 .118 1.057 .294 
    
Multiple drug use at Time 1 .549 5.164 .000 
Negative social sanctions at Time 2 -.008 -.073 .942 
Explicit identification at Time 2 .147 1.360 .178 
    
Multiple drug use at Time 1 .549 5.420 .000 
Age at Time 2 -.077 -.811 .420 
Explicit identification at Time 2 .159 1.545 .127 
    
Multiple drug use at Time 1 .541 5.290 .000 
Age of first use at Time 2 -.041 -.426 .671 
Explicit identification at Time 2 .137 1.333 .187 
    
Multiple drug use at Time 1 .525 5.266 .000 
Education at Time 2 .180 1.969 .053 
Explicit identification at Time 2 .155 1.560 .123 
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CHAPTER 5 - Discussion and conclusion 
This research aimed to develop a better understanding of the different drug use 
trajectories for young people who use or are at risk of using illicit drugs. Given that current 
research is unable to predict future trajectories or ongoing patterns of drug use, this study 
examined whether an individual’s implicit and/or explicit identification with drug use plays a 
role in the type and severity of their future drug use. It also assessed whether patterns of 
drug use such as the frequency, recency and use of multiple drugs, may impact the way a 
person implicitly identifies with their drug use or the extent to which a person sees drug 
use as part of their self-identity. This study is the first research that assesses implicit 
identification with drug use as a possible predictor of movement from occasional use to 
regular use of hard drugs. The main findings of the research are discussed below. 
Although many of the hypotheses were not supported, the research nonetheless provides 
insight into the relationship between implicit and explicit identification and drug use.   
Participants’ characteristics 
While numerous studies have been conducted with people who inject drugs, there are few 
studies that have been done on young at risk samples prior to or in the process of starting 
drug use. The relationship between participants’ characteristics and illicit drug use found 
within this sample seem to back data from the few existing Australian studies on young at 
risk people and provide a further description of an understudied group who are at risk of 
transitioning to injecting drug use (Lea et al., 2015). Data from this sample supports 
existing evidence that young people who use illicit substances are more likely to drop out 
of high school, experience negative social sanctions, are unemployed, are more likely to 
come into contact with others who use and/or inject and are part of a drug-using social 
network. Almost two thirds of the sample reported being unemployed, having left school by 
year 10, and having a close call with police or being arrested. Peer networks have been 
identified in the literature as being particularly influential in determining drug use pathways 
(Creemers et al., 2010; Hawkins et al., 1992; Simons-Morton & Chen, 2006). More than 
92% of this sample reported having friends who use drugs and over 80% reported having 
friends who inject drugs at least once a month. This research provides further evidence 
that within the social context in which these people live, the chances that they will engage 
in some form of drug use are high. Once again, given that known predictors of drug use 
are prevalent for this group, why some will transition into more hazardous drug-using 
lifestyles and others will not, remains an interesting question. 
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Implicit identification and seriousness of drug use 
This research assessed participants’ implicit and explicit identification with their drug use 
to determine whether identification relates to their drug use pathway. Based on previous 
research it was hypothesised that implicit associations between self and drug use would 
be stronger among people who use hard drugs regularly. Data at Time 1 indicate that, as 
predicted, implicit associations between self and drug use were stronger among 
participants who were injecting than people who were not, suggesting that those people 
who use harder drugs have a stronger identification with their drug use. However this 
pattern was not repeated at Time 2 with the smaller size sample. Further analysis also did 
not show an increase in the frequency and recency of drug use among participants who 
showed a stronger implicit association between self and drug use over time. Despite the 
finding that these variables were all significantly correlated with each other across time, 
neither implicit nor explicit identification was able to predict changes in frequency or 
recency of drug use across time.   
It was also hypothesised that an increase in the frequency and recency of drug use would 
be associated with stronger implicit associations between self and drug use over time. 
Analysis of the data, however, did not support this prediction, with frequency and recency 
of use unable to account for independent variance in either implicit or explicit identification 
with drug use. Lastly, the study hypothesised that participants who showed a strong 
implicit association between self and drug use would increase their use of multiple drugs 
over time. Again analyses were unable to support this hypothesis and did not show that 
stronger implicit identification between self and drug use led to an increase in the number 
of different types of drugs used over time. Seriousness of drug use was then 
operationalised as a combination of frequency of drug use, recency of drug use, and 
multiple drug use. Once seriousness of drug use was controlled for at time 1, neither 
implicit identification nor explicit identification with drugs was able to significantly predict 
seriousness of drug use at time 2.   
Self-identification in drug-using behaviour versus identification in recovery 
Evidence suggests that drug use can become bound up with identity and that underpinning 
long term recovery from addiction is the reconstruction of a non-addict identity. 
Identification appears to play an important role in recovery from drug use with literature 
highlighting the importance of separating the self-concept from drug use for successful 
recovery from drug dependence (McIntosh & McKeganey, 2000; Siobain, 2015; Waldorf & 
Biernacki, 1981). Research on recovery shows that whilst many people who use hard 
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drugs are able to stop using temporarily, they often revert back to drug use, with multiple 
transitions in and out of serious drug use being common for many drug users (Beynon, 
Bellis & McVeigh, 2006; Galai, Safaeian, Vlahov, Bolotin & Celentano, 2003; Hser, 
Hoffman, Grella & Anglin 2001). Wolff et al. (2015) looked at the role implicit associations 
played in recovery and found implicit identification with drugs and alcohol to be the best 
predictor of length of time that people remained in the rehabilitation centres. This finding is 
particularly important because research indicates that the longer a person spends in 
treatment, the better their chances of long term recovery from substance use (Evans, Li & 
Hser, 2009; Satre, Mertens, Areán & Weisner, 2004; Flynn, Joe, Broome, Simpson & 
Brown, 2003). Therefore based on previous research, Wolff et al.’s findings would suggest 
that implicit identification with drugs during recovery might be a significant predictor of 
treatment outcome.  
Why was implicit identification with drug use able to predict length of time in treatment 
centres in Wolff et al. (2015) but not intensity and frequency of drug use in a non-treatment 
setting in this research? It is possible that differences in the samples in the two studies 
may account for differences in the predictive role of implicit identification. In Wolff et al. 
(2015) the sample was older (mean age 34.8 years) and the participants were undergoing 
rehabilitation for alcohol and/or drug addiction. In the current sample the mean age was 
approximately 22 years and participants were either using or at risk of using illicit drugs 
and perhaps had not yet developed more entrenched patterns of drug use. Therefore the 
two samples are likely to differ in terms of their dependence on their drug of choice. In 
Wolff et al. (2015) all participants reported substance dependence prior to entering 
rehabilitation with participants having previously been treated for dependence an average 
of 4.43 times (SD = 5.87).  
Another possible reason for this research not being able to extend the findings of Wolff et 
al. (2015) is that self-identification with drugs may play a different role in transitioning to 
drug use as it does in recovery from addiction. As discussed earlier, an important part of 
the recovery process is the reconstruction of a non-addict identity (Gibson et al., 2004; 
Hughes, 2007; McIntosh & McKeganey, 2000). This involves detangling the drug-using 
identity from the non-user. The reconstruction of a new non-user identity requires breaking 
down previous destructive patterns of behaviour, and involves lifestyle changes that may 
require moving to a new location or changing social networks to support the new identity 
(Gibson et al., 2004; Hughes, 2007; McKeganey, 2001). Hence not only does it involve a 
narrative of recovery, but new social interests and new routines need to be developed. It 
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may only be in the rehabilitation phase that people who are dependent on drugs come to 
first identify themselves as an addict before they begin to reconstruct a non-addict identity. 
For example, the 12-Step approach -- a structured approach traditionally used by 
Alcoholics Anonymous to facilitate recovery from alcohol abuse -- has increasingly been 
used in drug treatment programs (Fiorentine & Hillhouse, 2000; Morgenstern, Kahler, Frey 
& Labouvie, 1996, Wallace, 1996). Cognitive restructuring is an important part of the 12-
Step approach in which the addict needs to first identify as an addict before they can start 
the recovery process (Steigerwald & Stone, 1999). According to these recovery programs, 
it is only after one has accepted this definition of being a dependent user that the person is 
able to relinquish routines, habits and any previously held understanding of themselves as 
linked to substance use. Only then can they be replaced with new behaviours and an 
acceptance of a new non-user identity (Kellogg, 1993; Stall & Biernacki, 1986; Steigerwald 
& Stone, 1999).   
Therefore, for those people who are recovering from substance use, self-identification with 
alcohol/drugs is an important first step in their recovery. It is possible that this self-
identification as an addict then reinforces drug use as part of their self-concept. Only once 
they can define themselves as an addict can they move towards change and establish a 
new non-user identity. Becoming a member of a non-drug-using social network is seen as 
crucial to the recovery process and involves establishing social networks that support the 
new identity (Mawson, Best, Beckwith, Dingle & Lubman, 2015). It is most likely in this 
phase that their implicit identification of themselves as dependent users starts to change to 
non-identification with substance use. It follows that perhaps those individuals who still 
continue to implicitly identify with their drug use while in treatment are those less likely to 
successfully complete their treatment. An alternate explanation is that the recovery 
programs require people to acknowledge explicitly their identification with drugs. This 
process of creating a greater explicit identification perhaps facilitates changes in implicit 
identification as well. It is possible that when they start to change their explicit 
identification, the way they see themselves moves from their unconscious to their 
conscious mind. It is only then that they can directly confront their drug-using identity in an 
effort to change it to a non-using identity.   
Another possible explanation for changes in implicit identification with drugs is to look at 
the interplay of automatic and controlled processes. The associative-propositional 
evaluation (APE) model (Gawronski & Bodenhausen, 2007) specifies that implicit and 
explicit evaluations are the product of two separate mental processes. These responses 
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can be different but this does not imply that people hold two different attitudes toward the 
same object (Wilson et al., 2000). Implicit evaluations are assumed to be the outcome of 
associative processes and explicit evaluations are assumed to be the outcome of 
propositional processes. These two processes influence one another and the specific 
interplay of the two processes (in this case the implicit and explicit identification with drug 
use) can lead to corresponding and sometimes to non-corresponding evaluations for the 
two types of responses. The influence of the automatic and controlled processes over 
each other can possibly explain how explicit acknowledgment of a user identity during 
treatment might be a step in changing one’s implicit identification. 
In comparison, for those people who are transitioning into drug use, the more entrenched 
they become in patterns of drug use and in drug-using social networks, the more they may 
identify with the drug-using group and internalise the values and the norms of this group 
which are likely to be based around drug use (Biernacki, 1986, Mawson et al., 2015). Data 
from this research also found the number of friends that use drugs to be significantly 
related to drug use frequency over time. This suggests that entrenchment in drug-using 
social network and patterns of drug-using behaviour are closely linked. Implicit 
identification may develop gradually, with the more entrenched people become in drug-
using networks and routines, the more they begin to implicitly identify with their drug use. It 
is possible therefore that implicit identification takes longer to form among those new to 
drug use in this research compared to the sample of dependent users in Wolff et al.’s 
study who had already commenced rehabilitation. Perhaps it is the case that a person 
needs to be more entrenched in a drug-using network before implicit and/or explicit 
identification with drug use has an effect on drug use behaviour. This may explain why 
implicit identification with drug use was not found to predict future aspects of participants’ 
drug use, but rather was seen to be tracking drug use. 
Tracking drug-using behaviour 
Despite the lack of support for the research hypotheses, the results show that implicit 
identification reflects participants’ levels of drug use. Even though implicit and explicit 
identification with drug use was not found to predict aspects of future drug use, the results 
suggest that it may be a marker of drug-using behaviour as identification was shown to 
mirror ongoing behaviour. In other words, the more a person uses drugs, the more they 
see themselves as a drug user both implicitly and explicitly. 
As discussed in chapter one, there are several risk factors that are known to predict 
transition to serious drug use, yet little is known about the etiology of the different 
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pathways that young at risk individuals will follow. A young person’s sense of self-worth 
can be fragile and being exposed to the known risk factors associated with transitioning to 
drug use such as homelessness, dysfunctional family life, dropping out of high school, may 
all contribute to a negative self-concept (Coates & McKenzie-Mohr, 2010; Fergusson & 
Lynskey, 1996; Kandel, 1982). These young people may easily become entrenched in 
street life and a drug-using culture that provides them with both social support and 
acceptance. Acceptance by drug-using peer networks may then increase entrenchment 
into a drug-using lifestyle fostering an environment that reinforces drug-using behaviour as 
well as exposure to injecting (Haller et al., 2010). It is well established that peer networks 
exert a profound influence on the transitioning to harder drug use (Creemers et al., 2010; 
Hawkins et al., 1992; Simons-Morton & Chen, 2006), but the exact role it plays needs to 
be further investigated. Future research should measure variables that relate to 
entrenchment in a drug-using lifestyle as possible determinants of drug use trajectories.  
In addition to the influence of peer networks, another potentially important variable in 
understanding drug use trajectories is habits and whether those people who identify more 
strongly with their drug of choice are driven by their drug using habits. Habits, behavioural 
routines and social networks are all intertwined and could certainly have an influence on a 
person’s sense of self and identity (Gibson et al., 2004; Hughes, 2007; McIntosh & 
McKeganey, 2000). It would be interesting to include drug using habits as a variable in 
future research to examine whether identification with drug use predicts pathways of use 
over and above drug habits. 
Reliability of IAT on drug-using samples 
The IAT was designed to measure automatic associations between concepts and 
attributes. The validity and reliability of the IAT has been well documented (Egloff & 
Shmukle, 2002; Greenwald & Farnham, 2000; Greenwald & Nosek; 2001; Greenwald, 
2010). Yet data from this research shows just under half of the participants had recently 
used substances prior to completing the IAT. It is possible that this drug use may have 
influenced their ability to complete the IAT task appropriately. This point is illustrated in a 
study by Aberson and Beeney (2007), where lower reliabilities were found on the IAT 
scores for participants who recently used marijuana. The current research was able to add 
to this debate around the reliability of the IAT with people who have recently used illicit 
substances by examining the standard deviations on the IAT scores as a function of 
whether the participants had used drugs on that day or not. This analysis indicates that 
variability in reaction time did not differ between those who used drugs on the day of 
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testing and those who had not (refer to Table 6 in Results). This finding suggests that the 
IAT may be a reliable measure to assess implicit associations among people that may be 
using drugs at the time that they complete the IAT. 
Limitations and future directions 
Research has shown that implicit identification has been found to predict unique variance 
in drinking outcomes (Gray, LaPlante, Bannon, Ambady & Shaffer, 2011; Lindgren et al., 
2013) as well as length of time spent in rehabilitation centres for alcohol and drug 
dependence (Wolff et al., 2015). The current study did not support the idea that implicit 
identification with drug use can predict future drug related behaviour. Aside from the 
conceptual reasons cited above there are some practical reasons why this lack of support 
may be the case. Because of the transient nature of this sample, recontacting participants 
proved extremely difficult and as a result the Time 2 sample was underpowered. Only 78 
participants were recontacted at Time 2 over a 20 month period compared to the original 
sample of 228 at Time 1. Contact details for the majority of participants had changed 
between the two time points. Their phones had been disconnected, locations they had 
previously frequented had changed, with many peers not knowing where their friends had 
moved to. Additionally, several of the participants had been arrested in the interim and 
were in custodial settings and therefore not able to be recontacted. The small sample size 
at Time 2 is likely to have limited the ability to find a statistically significant association 
between implicit identification and patterns of future drug use.   
Further, this study is not perfectly controlled as would be the case in a laboratory study. 
For example, while the average time lag between completion of the measures at Time 1 
and Time 2 was 5.5 months, recontacting of participants actually ranged from 61 to 594 
days between the initial and follow up survey session. It is possible that a longer time 
period between the two survey sessions is required in order to see actual changes in 
implicit associations and drug-using behaviour. In addition, the difficulties experienced in 
longitudinal recruitment may result in this sample not being as representative of an at risk 
youth population as one would hope. Perhaps those that are most at risk of serious drug 
use could not be traced for the follow up survey. It is likely the participants who have the 
most chaotic lifestyles and/or are possibly in custodial settings are hardest to recontact. 
Ideally future longitudinal research should be designed in such a way as to capture the 
more vulnerable and marginalised members of this at risk population to overcome the 
above short comings in order to better understand drug use trajectories.  
65 
Another limitation of this research concerns the accuracy of self-reported data. Even 
though there is previous literature that suggests that drug users are honest in their 
reporting of their drug related practices (Darke, 1998; Grella, Anglin, & Wugalter, 1997; 
Zanis, McLellan, & Randall, 1994), the stigma that surrounds drug use may influence 
participant responses. Social stigma and discrimination encountered by people who inject 
drugs together with the illegal nature of drug use, may impact the willingness of 
participants to openly discuss and be honest about their drug-using behaviours. In order to 
maximise reliable reporting, this research was designed as a self-administered survey to 
overcome under-reporting that is more common in an interviewer-administered survey 
(Harrison, 1997). However, it would be preferable for future research to use objective 
measures of the different aspects of drug use behaviour, such as urinalysis and hair 
analysis. In addition, it would be ideal if more than one implicit measure was included in 
the survey in order to ensure reliability and validity of the implicit data.  
Finally, as discussed earlier, when comparing results from this research with findings from 
research on people in drug treatment facilities, possible questions regarding the role of 
implicit identification were raised. Previous research suggests implicit identification with 
drugs and alcohol to be the best predictor of length of time that people remained in 
rehabilitation centres (Wolff et al., 2015). As length of time in rehabilitation is related to 
long term treatment success (Evans et al., 2009; Satre et al., 2004; Flynn et al., 2003), the 
importance of implicit identification is highlighted. It is possible that those individuals who 
still continue to implicitly identify with their drug use while in treatment are those who are 
more likely to relapse after rehabilitation. Further investigation into implicit identification 
and relapse rates could yield interesting results regarding the role of implicit identification 
with relapse to drug use after recovery.   
Concluding comments 
Young people who may use drugs occasionally but are thought to be at risk of transitioning 
to regular use of hard drugs have become an area of considerable concern at both state 
and federal government levels and have been declared a priority population in the 
Australian Fourth National Hepatitis C Strategy (Australian Government Department of 
Health and Ageing, 2014). Not only is drug use more common amongst young people, but 
they are less likely than older drug users to access harm reduction and other healthcare 
facilities where they can obtain medical and social services (Bailey et al., 2003; Walker & 
Reibel, 2013; Wilson et al., 2003). Young people are also less likely to practice safe 
injecting behaviour and more likely to share needles and other injecting equipment (Buxton 
66 
et al., 2004; Day et al., 2005, Kerr et al., 2009). This high risk behaviour makes young 
injecting drug users especially vulnerable to seroconverting to HCV (Hahn et al., 2002). 
Reducing the potential for drug related harms requires a better understanding of the 
different drug use trajectories to limit movement from occasional drug use to regular use of 
harder drugs and to minimise the physical and psychosocial harms associated with drug 
use. While literature shows that identification with drug use plays an important role in both 
recovery from drug addiction and in predicting future alcohol dependence, its role in the 
pathway of on-going drug use is not as clear. In this study implicit identification with drugs 
was not found to play a causal role in transitioning to injecting or to independently 
predicting changes in drug-using behaviour over time. However, even though identification 
with drug use was not found to predict aspects of future drug use or seriousness of use 
over time, the results suggest that it may be a marker of drug-using behaviour as 
identification with drug use was shown to mirror ongoing drug-related behaviour. The 
intricate relationship that may exist between implicit identification with drug use, peer 
networks and entrenchment in a drug-using lifestyle should be further investigated to 
enable a clearer understanding of the possible role these factors may play in changes in 
drug use over time. Given the significant public health implications of regular drug use, and 
the particular risks associated with drug use among young people, it is important for future 
research to be designed around this at risk population that continues to investigate 
potential predictors of ongoing patterns of drug use in order to gain a clearer 
understanding of the different drug use trajectories for young at risk individuals.  
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APPENDICES 
Questionnaire  
 
1) In the last 12 months, did you use drugs and if so how often? 
Never used drugs  □ 0 
Not in the last 12 months □ 1  
Once or twice a year   □ 2 
Every few months   □ 3 
About once a month   □ 4 
Once a week or more   □ 5 
Every day    □ 6 
 
2) Have you ever injected drugs? 
No     □ 1 
Yes    □ 2 
 
3) When was the last time you used drugs? 
Today    □ 1  
Yesterday     □ 2 
Last week     □ 3 
More than a week ago   □ 4 
More than a month ago   □ 5 
More than 6 months ago  □ 6 
Never used drugs  □ 888 
   
4) What was the drug you last used? (mark only one answer) 
Heroin    □ 1  
Cannabis     □ 2 
Cocaine     □ 3 
LSD     □ 4 
Ecstasy    □ 5 
Ice/crystal    □ 6 
Speed    □ 7 
Ketamine    □ 8  
Benzos     □ 9 
Methadone/bupe    □ 10 
Prescription opioids   □ 11 
Other     □ 12 ___________________ 
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5) Have you used any of the following drugs in the past 12 months.  
Tick as many as you have used. 
Heroin    □ 1  
Cannabis     □ 2 
Cocaine     □ 3 
LSD     □ 4 
Ecstasy    □ 5 
Ice/crystal    □ 6 
Speed    □ 0 
Ketamine    □ 8  
Benzos     □ 9 
Methadone/bupe    □ 10 
Prescription opioids   □ 11 
Other     □ 12 ___________________ 
 
6) In the last 12 months, what was the main way that you used the drug of your choice? 
Smoked     □ 1 
Snorted     □ 2 
Swallowed     □ 3   
Injected      □ 4   
Other     □ 5 
I did not use drugs in last 12 months  □ 888 
 
7) Over the last months, did you ever think your use of drugs was beyond your control?  
Never or almost never    □   0 
Sometimes      □ 1  
Often       □ 2  
Always or almost always    □ 3  
I did not use drugs in last month  □ 888 
 
8) Over the last month, did the prospect of not obtaining drugs when you wanted them make 
you very anxious or worried?  
Never or almost never     □   0  
Sometimes      □ 1  
Often       □ 2  
Always or almost always    □ 3  
I did not use drugs in last month  □ 888 
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9) Over the last month, did you worry about your use of drugs?  
Not at all      □ 0 
A little      □ 1  
Quite a lot     □ 2 
A great deal     □ 3 
I did not use drugs in the last month □ 888 
 
10) Over the last month, did you wish you could stop permanently?  
Never or almost never    □ 0  
Sometimes     □ 1  
Often      □ 2  
Always or nearly always   □ 3 
I did not use drugs in the last month □ 888 
 
11) How difficult would you find it to stop permanently or go without?  
Not difficult     □ 0 
Quite difficult     □ 1  
Very difficult     □ 2 
Impossible     □ 3 
  
12) Have you either have a close call with the police or been arrested because of your use of 
dugs? 
No      □ 1 
Yes     □ 2 
 
13) Have you lost your job or been in trouble on the job because of using drugs, or have 
trouble with teachers or school authorities because of using drugs? 
No      □ 1 
Yes     □ 2 
  
14) Please answer the following statements from strongly disagree to strongly agree. 
 
1. Using drugs is part of the way I see myself 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
2. Using drugs is part of “who I am” 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
3. Using drugs is a large part of my daily life 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
4. Others view using drugs as part of my personality 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
5. It is easy to imagine myself as a person who doesn’t use drugs at all 
95 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
6. When I think of myself, I think of being “clean” 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
7. When I think of myself, I think if using drugs 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
8. When I think of myself, I identify with being “clean” 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
9. When I think of myself, I identify with using drugs  
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
10. Using drugs makes me feel closer to my friends 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
11. Using drugs makes me feel more confident or more able to talk in a social situation 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
12. Using drugs helps me stop worrying about a problem 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
13. Using drugs makes me feel better when down or depressed 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
14. Using drugs helps me celebrate good events 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
15. Using drugs helps me relax 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
16. Using drugs helps me keep going on a night out with friends 
Strongly disagree 1 2 3 4 5 6 7 Strongly agree 
 
15) How many of your fiends use (but not inject) drugs at least once a month on average? 
 
None of my friends  □ 1  
A few    □ 2  
About half    □ 3  
Most    □ 4 
All     □ 5 
 
16) How many of your fiends inject illicit drugs at least once a month? 
 
None of my friends  □ 1  
A few    □ 2  
About half    □ 3  
Most    □ 4 
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All     □ 5 
17) How do you think most of your close friends would feel about you using drugs occasionally? 
 
Don’t know    □ 1  
Disapprove    □ 2  
Neither disapprove nor approve □ 3  
Approve     □ 4 
 
18) How do you think most of your close friends would feel about you using drugs regularly? 
 
Don’t know    □ 1  
Disapprove    □ 2  
Neither disapprove nor approve □ 3  
Approve     □ 4 
 
19) Are you? 
Male     □ 1  
Female     □ 2  
Transgender    □ 3  
Intersex     □ 4 
 
20) How old are you? 
 
__________ years 
  
21) How old were you when you used illicit drugs for the first time 
 
_________ years 
 
I have never used illicit drugs  □ 0 
 
22) Highest Level of education? 
 
Primary     □ 1 
Up to and including year 10  □ 2 
Up to and including year 12  □ 3   
Diploma/Trade     □ 4   
Attended/completed university   □ 5 
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23) Main source of income ? 
 
Full time work    □ 1 
Part time work     □ 2 
Casual work    □ 3   
Contract work    □ 4   
Benefits     □ 5 
Student allowance   □ 6   
Dependent on parents   □ 7   
Crime     □ 8 
Other     □ 9   
No income    □ 10   
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Information sheet for participants 
 
Places to get help if you need it… 
  
 
ALBION STREET CENTRE 
Here you can see a doctor to get a hep C test or any other medical services, including sexual 
health and help for drug use. 
150 - 154 Albion Street, Surry Hills 2010  
T: 02 9332 9600  
W: http://www.sesiahs.health.nsw.gov.au/Albionstcentre/ 
 
YOUTHBLOCK HEALTH AND RESOURCE CENTRE 
Here you can get support and information specifically for young people about general health, 
mental health, alcohol and other drugs problems 
97 Church Street, Camperdown, 2050 
T: 02 9516 2233 
 
YOUTH OFF THE STREETS  
Youth Off the Streets can provide counselling and help for drug use and give you temporary 
emergency accommodation. 
133 O'Riordan St, Mascot 2020 
T: 02 9330 3500 
W: www.youthoffthestreets.com 
 
KIRKETON ROAD CENTRE 
Here you can see a doctor to get a hep C test or any other medical services, including mental 
health, sexual health and help for drug use. You can also get free needles and syringes until 6pm 
Monday-Friday and until 1:45pm on weekends and public holidays. 
Above the Darlinghurst Fire Station, entrance on Victoria Street, Darlinghurst 2010 
T: 02 9360-2766 
W: http://www.sesiahs.health.nsw.gov.au/sydhosp/services/kirketonroad.asp 
 
NEW SOUTH WALES USERS AND AIDS ASSOCIATION 
(NUAA) 
Here you can get help for drug use and free needles and syringes until 5pm. 
345 Crown Street, Surry Hills 2010 
T: 02 8354 7300 or 1800 644 413 (NSW only) 
W: www.nuaa.org.au/ 
 
OASIS YOUTH SUPPORT NETWORK 
Oasis can give you temporary emergency accommodation and other help including counseling 
and help for drug use. 
365 Crown Street, Surry Hills 2010 
T: 02 9331 2266 
W: http://salvos.org.au/oasis/ 
 
 
99 
 
Contact details for follow up survey 
 
Can we contact you in three/four months times to complete another survey like this? 
 
 
  No 
  Yes. Please give your... 
Name _________________________________ 
Phone Number   ________________________ 
Email _________________________________ 
 
OPTIONAL  
 
Contact details of a friend or family member (someone who can 
tell us where we can contact you if your mobile or email changes) 
 
Please note that the only information provided will be that you 
participated in a survey for the University of Queensland on young 
people’s attitudes and behaviours. 
Name_________________________________ 
Phone number_________________________ 
Email_________________________________ 
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Follow up contact Script to parent/guardian or friend 
 
Hi (insert name), 
My name is (insert name) and I work at the University of Queensland. (Insert name) 
completed a survey for us on the attitudes and behaviours of young people (insert time) 
months ago and provided your number/email if the contact details he/she left us changed. 
We are about to conduct a follow up study and need to make contact with (insert name). 
Do you know the best way to contact (insert name) at this current time?  
If you do not feel comfortable providing those details, would it be possible for you to pass 
my contact details (insert number/email) to (insert name)? 
 
Thank you 
 
 
 
